国内・海外ã®å¸‚å ´èª¿æŸ»ãƒ¬ãƒãƒ¼ãƒˆè²©å£²
- レãƒãƒ¼ãƒˆä¸€è¦§
Warning (2): session_start() [<a href='function.session-start'>function.session-start</a>]: open(/tmp//sess_884771a7daf0ada2f5743239aa1b8227, O_RDWR) failed: Disc quota exceeded (69) [CORE/Cake/Model/Datasource/CakeSession.php, line 745]Code Context$limit = 'must-revalidate'session_start - [internal], line ?? CakeSession::_startSession() - CORE/Cake/Model/Datasource/CakeSession.php, line 745 CakeSession::start() - CORE/Cake/Model/Datasource/CakeSession.php, line 219 CakeSession::write() - CORE/Cake/Model/Datasource/CakeSession.php, line 439 SessionComponent::write() - CORE/Cake/Controller/Component/SessionComponent.php, line 55 CategoriesController::detail() - APP/Controller/CategoriesController.php, line 451 ReflectionMethod::invokeArgs() - [internal], line ?? Controller::invokeAction() - CORE/Cake/Controller/Controller.php, line 499 Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 193 Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167 [main] - APP/webroot/index.php, line 118
Warning (2): session_start() [<a href='http://php.net/function.session-start'>function.session-start</a>]: Cannot send session cookie - headers already sent by (output started at /home/spi-information/www/lib/Cake/Utility/Debugger.php:797) [CORE/Cake/Model/Datasource/CakeSession.php, line 745]Code Context$limit = 'must-revalidate'session_start - [internal], line ?? CakeSession::_startSession() - CORE/Cake/Model/Datasource/CakeSession.php, line 745 CakeSession::start() - CORE/Cake/Model/Datasource/CakeSession.php, line 219 CakeSession::write() - CORE/Cake/Model/Datasource/CakeSession.php, line 439 SessionComponent::write() - CORE/Cake/Controller/Component/SessionComponent.php, line 55 CategoriesController::detail() - APP/Controller/CategoriesController.php, line 451 ReflectionMethod::invokeArgs() - [internal], line ?? Controller::invokeAction() - CORE/Cake/Controller/Controller.php, line 499 Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 193 Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167 [main] - APP/webroot/index.php, line 118
Warning (2): session_start() [<a href='http://php.net/function.session-start'>function.session-start</a>]: Cannot send session cache limiter - headers already sent (output started at /home/spi-information/www/lib/Cake/Utility/Debugger.php:797) [CORE/Cake/Model/Datasource/CakeSession.php, line 745]Code Context$limit = 'must-revalidate'session_start - [internal], line ?? CakeSession::_startSession() - CORE/Cake/Model/Datasource/CakeSession.php, line 745 CakeSession::start() - CORE/Cake/Model/Datasource/CakeSession.php, line 219 CakeSession::write() - CORE/Cake/Model/Datasource/CakeSession.php, line 439 SessionComponent::write() - CORE/Cake/Controller/Component/SessionComponent.php, line 55 CategoriesController::detail() - APP/Controller/CategoriesController.php, line 451 ReflectionMethod::invokeArgs() - [internal], line ?? Controller::invokeAction() - CORE/Cake/Controller/Controller.php, line 499 Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 193 Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167 [main] - APP/webroot/index.php, line 118
Warning (2): Cannot modify header information - headers already sent by (output started at /home/spi-information/www/lib/Cake/Utility/Debugger.php:797) [APP/View/Layouts/spi-information.ctp, line 2]Code Context$viewFile = '/home/spi-information/www/app/View/Layouts/spi-information.ctp' $dataForView = array( 'favorite_data' => array(), 'keywords' => array( (int) 0 => 'ä¹³ãŒã‚“治療薬', (int) 1 => '標的療法', (int) 2 => 'ホルモン療法', (int) 3 => '化å¦ç™‚法', (int) 4 => '女性ã®å¥åº·' ), 'summary' => array(), 'rrc' => array( (int) 0 => array( 'ReportRelationCategory' => array( [maximum depth reached] ) ), (int) 1 => array( 'ReportRelationCategory' => array( [maximum depth reached] ) ), (int) 2 => array( 'ReportRelationCategory' => array( [maximum depth reached] ) ) ), 'rrr_report_base_res' => array(), 'report_detail' => array( (int) 0 => array( 'id' => '45243', 'order_num' => '1', 'report_id' => '37546', 'title' => '目次', 'body' => '<p> <span style="font-weight:bold;">Table of Contents</span> </p> <p> <span style="font-weight:bold;">1 Executive Summary</span> <br /> 1.1 Market overview<br /> Exhibit 01: Executive Summary - Chart on Market Overview<br /> Exhibit 02: Executive Summary - Data Table on Market Overview<br /> Exhibit 03: Executive Summary - Chart on Global Market Characteristics<br /> Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape<br /> Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type<br /> Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapy<br /> Exhibit 07: Executive Summary - Chart on Incremental Growth<br /> Exhibit 08: Executive Summary - Data Table on Incremental Growth<br /> Exhibit 09: Executive Summary - Chart on Vendor Market Positioning </p> <p> <span style="font-weight:bold;">2 Market Landscape</span> <br /> 2.1 Market ecosystem<br /> Exhibit 10: Parent market<br /> Exhibit 11: Market Characteristics </p> <p> <span style="font-weight:bold;">3 Market Sizing</span> <br /> 3.1 Market definition<br /> Exhibit 12: Offerings of vendors included in the market definition<br /> 3.2 Market segment analysis<br /> Exhibit 13: Market segments<br /> 3.3 Market size 2023<br /> 3.4 Market outlook: Forecast for 2023-2028<br /> Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)<br /> Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%) </p> <p> <span style="font-weight:bold;">4 Historic Market Size</span> <br /> 4.1 Global breast cancer therapeutics market 2018 - 2022<br /> Exhibit 18: Historic Market Size - Data Table on global breast cancer therapeutics market 2018 - 2022 ($ billion)<br /> 4.2 Disease Type Segment Analysis 2018 - 2022<br /> Exhibit 19: Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion)<br /> 4.3 Therapy Segment Analysis 2018 - 2022<br /> Exhibit 20: Historic Market Size - Therapy Segment 2018 - 2022 ($ billion)<br /> 4.4 Geography Segment Analysis 2018 - 2022<br /> Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)<br /> 4.5 Country Segment Analysis 2018 - 2022<br /> Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion) </p> <p> <span style="font-weight:bold;">5 Five Forces Analysis</span> <br /> 5.1 Five forces summary<br /> Exhibit 23: Five forces analysis - Comparison between 2023 and 2028<br /> 5.2 Bargaining power of buyers<br /> Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028<br /> 5.3 Bargaining power of suppliers<br /> Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028<br /> 5.4 Threat of new entrants<br /> Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028<br /> 5.5 Threat of substitutes<br /> Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028<br /> 5.6 Threat of rivalry<br /> Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028<br /> 5.7 Market condition<br /> Exhibit 29: Chart on Market condition - Five forces 2023 and 2028 </p> <p> <span style="font-weight:bold;">6 Market Segmentation by Disease Type</span> <br /> 6.1 Market segments<br /> Exhibit 30: Chart on Disease Type - Market share 2023-2028 (%)<br /> Exhibit 31: Data Table on Disease Type - Market share 2023-2028 (%)<br /> 6.2 Comparison by Disease Type<br /> Exhibit 32: Chart on Comparison by Disease Type<br /> Exhibit 33: Data Table on Comparison by Disease Type<br /> 6.3 Invasive breast cancers - Market size and forecast 2023-2028<br /> Exhibit 34: Chart on Invasive breast cancers - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 35: Data Table on Invasive breast cancers - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 36: Chart on Invasive breast cancers - Year-over-year growth 2023-2028 (%)<br /> Exhibit 37: Data Table on Invasive breast cancers - Year-over-year growth 2023-2028 (%)<br /> 6.4 Ductal carcinoma in situ - Market size and forecast 2023-2028<br /> Exhibit 38: Chart on Ductal carcinoma in situ - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 39: Data Table on Ductal carcinoma in situ - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 40: Chart on Ductal carcinoma in situ - Year-over-year growth 2023-2028 (%)<br /> Exhibit 41: Data Table on Ductal carcinoma in situ - Year-over-year growth 2023-2028 (%)<br /> 6.5 Market opportunity by Disease Type<br /> Exhibit 42: Market opportunity by Disease Type ($ billion)<br /> Exhibit 43: Data Table on Market opportunity by Disease Type ($ billion) </p> <p> <span style="font-weight:bold;">7 Market Segmentation by Therapy</span> <br /> 7.1 Market segments<br /> Exhibit 44: Chart on Therapy - Market share 2023-2028 (%)<br /> Exhibit 45: Data Table on Therapy - Market share 2023-2028 (%)<br /> 7.2 Comparison by Therapy<br /> Exhibit 46: Chart on Comparison by Therapy<br /> Exhibit 47: Data Table on Comparison by Therapy<br /> 7.3 Targeted therapy - Market size and forecast 2023-2028<br /> Exhibit 48: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 49: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 50: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)<br /> Exhibit 51: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)<br /> 7.4 Hormonal therapy - Market size and forecast 2023-2028<br /> Exhibit 52: Chart on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 53: Data Table on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 54: Chart on Hormonal therapy - Year-over-year growth 2023-2028 (%)<br /> Exhibit 55: Data Table on Hormonal therapy - Year-over-year growth 2023-2028 (%)<br /> 7.5 Chemotherapy - Market size and forecast 2023-2028<br /> Exhibit 56: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 57: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 58: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)<br /> Exhibit 59: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)<br /> 7.6 Market opportunity by Therapy<br /> Exhibit 60: Market opportunity by Therapy ($ billion)<br /> Exhibit 61: Data Table on Market opportunity by Therapy ($ billion) </p> <p> <span style="font-weight:bold;">8 Customer Landscape</span> <br /> 8.1 Customer landscape overview<br /> Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria </p> <p> <span style="font-weight:bold;">9 Geographic Landscape</span> <br /> 9.1 Geographic segmentation<br /> Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)<br /> Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)<br /> 9.2 Geographic comparison<br /> Exhibit 65: Chart on Geographic comparison<br /> Exhibit 66: Data Table on Geographic comparison<br /> 9.3 North America - Market size and forecast 2023-2028<br /> Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)<br /> Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)<br /> 9.4 Europe - Market size and forecast 2023-2028<br /> Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)<br /> Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)<br /> 9.5 Asia - Market size and forecast 2023-2028<br /> Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)<br /> Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)<br /> 9.6 Rest of World (ROW) - Market size and forecast 2023-2028<br /> Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)<br /> Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)<br /> 9.7 US - Market size and forecast 2023-2028<br /> Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)<br /> Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)<br /> 9.8 Germany - Market size and forecast 2023-2028<br /> Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)<br /> Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)<br /> 9.9 Canada - Market size and forecast 2023-2028<br /> Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)<br /> Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)<br /> 9.10 UK - Market size and forecast 2023-2028<br /> Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)<br /> Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)<br /> 9.11 China - Market size and forecast 2023-2028<br /> Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)<br /> Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)<br /> 9.12 Market opportunity By Geographical Landscape<br /> Exhibit 103: Market opportunity By Geographical Landscape ($ billion)<br /> Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion) </p> <p> <span style="font-weight:bold;">10 Drivers, Challenges, and Trends</span> <br /> 10.1 Market drivers<br /> 10.2 Market challenges<br /> 10.3 Impact of drivers and challenges<br /> Exhibit 105: Impact of drivers and challenges in 2023 and 2028<br /> 10.4 Market trends </p> <p> <span style="font-weight:bold;">11 Vendor Landscape</span> <br /> 11.1 Overview<br /> 11.2 Vendor landscape<br /> Exhibit 106: Overview on Criticality of inputs and Factors of differentiation<br /> 11.3 Landscape disruption<br /> Exhibit 107: Overview on factors of disruption<br /> 11.4 Industry risks<br /> Exhibit 108: Impact of key risks on business </p> <p> <span style="font-weight:bold;">12 Vendor Analysis</span> <br /> 12.1 Vendors covered<br /> Exhibit 109: Vendors covered<br /> 12.2 Market positioning of vendors<br /> Exhibit 110: Matrix on vendor position and classification<br /> 12.3 AbbVie Inc.<br /> Exhibit 111: AbbVie Inc. - Overview<br /> Exhibit 112: AbbVie Inc. - Product / Service<br /> Exhibit 113: AbbVie Inc. - Key news<br /> Exhibit 114: AbbVie Inc. - Key offerings<br /> 12.4 Amgen Inc.<br /> Exhibit 115: Amgen Inc. - Overview<br /> Exhibit 116: Amgen Inc. - Product / Service<br /> Exhibit 117: Amgen Inc. - Key offerings<br /> 12.5 AstraZeneca Plc<br /> Exhibit 118: AstraZeneca Plc - Overview<br /> Exhibit 119: AstraZeneca Plc - Product / Service<br /> Exhibit 120: AstraZeneca Plc - Key news<br /> Exhibit 121: AstraZeneca Plc - Key offerings<br /> 12.6 Bristol Myers Squibb Co.<br /> Exhibit 122: Bristol Myers Squibb Co. - Overview<br /> Exhibit 123: Bristol Myers Squibb Co. - Product / Service<br /> Exhibit 124: Bristol Myers Squibb Co. - Key news<br /> Exhibit 125: Bristol Myers Squibb Co. - Key offerings<br /> 12.7 Clovis Oncology Inc.<br /> Exhibit 126: Clovis Oncology Inc. - Overview<br /> Exhibit 127: Clovis Oncology Inc. - Product / Service<br /> Exhibit 128: Clovis Oncology Inc. - Key offerings<br /> 12.8 Daiichi Sankyo Co. Ltd.<br /> Exhibit 129: Daiichi Sankyo Co. Ltd. - Overview<br /> Exhibit 130: Daiichi Sankyo Co. Ltd. - Product / Service<br /> Exhibit 131: Daiichi Sankyo Co. Ltd. - Key news<br /> Exhibit 132: Daiichi Sankyo Co. Ltd. - Key offerings<br /> 12.9 Eisai Co. Ltd.<br /> Exhibit 133: Eisai Co. Ltd. - Overview<br /> Exhibit 134: Eisai Co. Ltd. - Business segments<br /> Exhibit 135: Eisai Co. Ltd. - Key offerings<br /> Exhibit 136: Eisai Co. Ltd. - Segment focus<br /> 12.10 Eli Lilly and Co.<br /> Exhibit 137: Eli Lilly and Co. - Overview<br /> Exhibit 138: Eli Lilly and Co. - Product / Service<br /> Exhibit 139: Eli Lilly and Co. - Key news<br /> Exhibit 140: Eli Lilly and Co. - Key offerings<br /> 12.11 Exelixis Inc.<br /> Exhibit 141: Exelixis Inc. - Overview<br /> Exhibit 142: Exelixis Inc. - Product / Service<br /> Exhibit 143: Exelixis Inc. - Key offerings<br /> 12.12 F. Hoffmann La Roche Ltd.<br /> Exhibit 144: F. Hoffmann La Roche Ltd. - Overview<br /> Exhibit 145: F. Hoffmann La Roche Ltd. - Business segments<br /> Exhibit 146: F. Hoffmann La Roche Ltd. - Key news<br /> Exhibit 147: F. Hoffmann La Roche Ltd. - Key offerings<br /> Exhibit 148: F. Hoffmann La Roche Ltd. - Segment focus<br /> 12.13 GlaxoSmithKline Plc<br /> Exhibit 149: GlaxoSmithKline Plc - Overview<br /> Exhibit 150: GlaxoSmithKline Plc - Business segments<br /> Exhibit 151: GlaxoSmithKline Plc - Key news<br /> Exhibit 152: GlaxoSmithKline Plc - Key offerings<br /> Exhibit 153: GlaxoSmithKline Plc - Segment focus<br /> 12.14 Merck and Co. Inc.<br /> Exhibit 154: Merck and Co. Inc. - Overview<br /> Exhibit 155: Merck and Co. Inc. - Business segments<br /> Exhibit 156: Merck and Co. Inc. - Key news<br /> Exhibit 157: Merck and Co. Inc. - Key offerings<br /> Exhibit 158: Merck and Co. Inc. - Segment focus<br /> 12.15 Novartis AG<br /> Exhibit 159: Novartis AG - Overview<br /> Exhibit 160: Novartis AG - Business segments<br /> Exhibit 161: Novartis AG - Key offerings<br /> Exhibit 162: Novartis AG - Segment focus<br /> 12.16 Pfizer Inc.<br /> Exhibit 163: Pfizer Inc. - Overview<br /> Exhibit 164: Pfizer Inc. - Product / Service<br /> Exhibit 165: Pfizer Inc. - Key news<br /> Exhibit 166: Pfizer Inc. - Key offerings<br /> 12.17 Viatris Inc.<br /> Exhibit 167: Viatris Inc. - Overview<br /> Exhibit 168: Viatris Inc. - Business segments<br /> Exhibit 169: Viatris Inc. - Key news<br /> Exhibit 170: Viatris Inc. - Key offerings<br /> Exhibit 171: Viatris Inc. - Segment focus </p> <p> <span style="font-weight:bold;">13 Appendix</span> <br /> 13.1 Scope of the report<br /> 13.2 Inclusions and exclusions checklist<br /> Exhibit 172: Inclusions checklist<br /> Exhibit 173: Exclusions checklist<br /> 13.3 Currency conversion rates for US$<br /> Exhibit 174: Currency conversion rates for US$<br /> 13.4 Research methodology<br /> Exhibit 175: Research methodology<br /> Exhibit 176: Validation techniques employed for market sizing<br /> Exhibit 177: Information sources<br /> 13.5 List of abbreviations<br /> Exhibit 178: List of abbreviations </p> ', 'update_date' => '2024-03-06 16:57:10' ) ), 'report_pdf' => array(), 'report_base' => array( 'id' => '37546', 'pj_code' => '999999', 'title_main' => 'ä¹³ãŒã‚“治療薬ã®ä¸–ç•Œå¸‚å ´ï¼ˆ2024-2028）', 'title_volume' => '', 'title_volumetitle' => '', 'charge_person' => '37', 'subtitle' => 'Global Breast Cancer Therapeutics Market 2024-2028', 'keyword1' => 'ä¹³ãŒã‚“治療薬', 'keyword2' => '標的療法', 'keyword3' => 'ホルモン療法', 'keyword4' => '化å¦ç™‚法', 'keyword5' => '女性ã®å¥åº·', 'summary1' => '', 'summary2' => '', 'summary3' => '', 'language' => '2', 'disp_status' => '1', 'publish_status' => '1', 'publish_date' => '2024-01-18', 'publish_date_ymdsp' => false, 'publish_check' => null, 'price_reserve' => '0', 'price_reserve2' => '0', 'price_reserve3' => '0', 'price_reserve4' => '0', 'price_reserve5' => '0', 'license_reserve' => '', 'license_reserve2' => '', 'license_reserve3' => '', 'license_reserve4' => '', 'license_reserve5' => '', 'price' => '2500', 'price2' => '4000', 'price3' => '0', 'price4' => '0', 'price5' => '0', 'price6' => '0', 'price7' => '0', 'price8' => '0', 'license' => 'Single', 'license2' => 'Enterprise', 'license3' => '', 'license4' => '', 'license5' => '', 'license6' => '', 'license7' => '', 'license8' => '', 'unit_e' => null, 'unit' => 'USD', 'style_format' => 'PDF', 'about_flag' => '0', 'style_page' => '168', 'publishing_office' => 'TechNavio', 'note' => '※ã”請求ã¯ã€ãŠç”³è¾¼æ—¥ã®TTSレートã§å††æ›ç®—ã—ã€æ¶ˆè²»ç¨Žã‚’åŠ ãˆãŸé‡‘é¡ã«ãªã‚Šã¾ã™ã€‚<br />※本レãƒãƒ¼ãƒˆã¯ã€è‹±æ–‡ã§ã™ã€‚PDF(é›»å媒体)ã§ã®ç´å“ã¨ãªã‚Šã¾ã™ã€‚<br />※本レãƒãƒ¼ãƒˆã¯å–り寄ã›ã¨ãªã‚Šã¾ã™ã®ã§ã€ç”³ã—è¾¼ã¿ã‹ã‚‰ãŠå±Šã‘ã¾ã§ã€å¤šå°‘時間ãŒæŽ›ã‹ã‚‹å ´åˆãŒã”ã–ã„ã¾ã™ã€‚', 'color' => '2', 'scolor' => null, 'outline' => '<p> ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã¯2023å¹´ã‹ã‚‰2028å¹´ã«156å„„4,000万米ドルã€äºˆæ¸¬æœŸé–“ä¸ã®CAGRã¯8.4%ã§æˆé•·ã™ã‚‹ã¨äºˆæ¸¬ã•ã‚Œã¾ã™ã€‚ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã¯ã€å…¨ä½“çš„ãªåˆ†æžã€å¸‚å ´è¦æ¨¡ã¨äºˆæ¸¬ã€å‚¾å‘ã€æˆé•·ãƒ‰ãƒ©ã‚¤ãƒãƒ¼ã€èª²é¡Œã€ãŠã‚ˆã³ç´„25ã®ãƒ™ãƒ³ãƒ€ãƒ¼ã‚’ã‚«ãƒãƒ¼ã™ã‚‹ãƒ™ãƒ³ãƒ€ãƒ¼åˆ†æžã‚’æä¾›ã—ã¾ã™ã€‚ </p> <p> ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã¯ã€ç¾åœ¨ã®å¸‚å ´ã‚·ãƒŠãƒªã‚ªã€æœ€æ–°ã®å‚¾å‘ã¨æŽ¨é€²åŠ›ã€ãŠã‚ˆã³å…¨ä½“çš„ãªå¸‚å ´ç’°å¢ƒã«é–¢ã™ã‚‹æœ€æ–°ã®åˆ†æžã‚’æä¾›ã—ã¾ã™ã€‚ä¹³ãŒã‚“罹患率ã®ä¸Šæ˜‡ã€å …調ãªãƒ‘イプラインã¨æ–°è–¬æ‰¿èªã€æ‚£è€…を支æ´ã™ã‚‹å–り組ã¿ã®å¢—åŠ ãªã©ãŒå¸‚å ´ã‚’ç‰½å¼•ã—ã¦ã„ã¾ã™ã€‚ </p> <p> <span style="font-weight:bold;">調査範囲</span> </p> <ul class="rfp_mar-b1"> <li> <span style="font-weight:bold;">å¸‚å ´ã‚»ã‚°ãƒ¡ãƒ³ãƒˆ</span> <br /> <span style="font-weight:bold;">➣ 疾患タイプ別</span> <br /> 　　◇ 浸潤性乳ãŒã‚“<br /> 　　◇ éžæµ¸æ½¤æ€§ä¹³ãŒã‚“（DCIS）<br /> <span style="font-weight:bold;">➣ セラピー別</span> <br /> 　　◇ 標的療法<br /> 　　◇ ホルモン療法<br /> 　　◇ 化å¦ç™‚法<br /> <span style="font-weight:bold;">➣ 地域別</span> <br /> 　　◇ 北アメリカ<br /> 　　◇ ヨーãƒãƒƒãƒ‘<br /> 　　◇ アジア<br /> 　　◇ 世界ã®ãã®ä»–ã®åœ°åŸŸï¼ˆROW） </li> </ul> <p> 本調査ã§ã¯ã€ä»Šå¾Œæ•°å¹´é–“ã®ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®æˆé•·ã‚’牽引ã™ã‚‹ä¸»ãªè¦å› ã®1ã¤ã¨ã—ã¦ã€æ–°ãŸãªæ–°è¦æ²»ç™‚薬を挙ã’ã¦ã„ã¾ã™ã€‚ã¾ãŸã€æ”¹å–„ã•ã‚ŒãŸè¨ºæ–モダリティã®åˆ©ç”¨å¯èƒ½æ€§ã‚„戦略的ææºã®å¢—åŠ ã¯ã€å¸‚å ´ã®å¤§ããªéœ€è¦ã«ã¤ãªãŒã£ã¦ã„ã¾ã™ã€‚ </p> <p>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã«é–¢ã™ã‚‹ãƒ¬ãƒãƒ¼ãƒˆã¯ã€æ¬¡ã®åˆ†é‡Žã‚’ã‚«ãƒãƒ¼ã—ã¦ã„ã¾ã™ã€‚</p> <ul class="rfp_mar-b1"> <li>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®è¦æ¨¡</li> <li>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®äºˆæ¸¬</li> <li>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®æ¥ç•Œåˆ†æž</li> </ul> <p>å …ç‰¢ãªãƒ™ãƒ³ãƒ€ãƒ¼åˆ†æžã¯ã€ã‚¯ãƒ©ã‚¤ã‚¢ãƒ³ãƒˆãŒå¸‚å ´ã§ã®åœ°ä½ã‚’å‘上ã•ã›ã‚‹ã®ã«å½¹ç«‹ã¤ã‚ˆã†ã«è¨è¨ˆã•ã‚Œã¦ã„ã¾ã™ã€‚</p> <ul class="rfp_mar-b1"> <li> <span style="font-weight:bold;">調査ä¼æ¥</span> <br /> ➣ AbbVie Inc.<br /> ➣ Amgen Inc.<br /> ➣ AstraZeneca Plc<br /> ➣ Bristol Myers Squibb Co.<br /> ➣ Clovis Oncology Inc.<br /> ➣ 第一三共（Daiichi Sankyo Co. Ltd.）<br /> ➣ エーザイ（Eisai Co. Ltd.）<br /> ➣ Eli Lilly and Co.<br /> ➣ Exelixis Inc.<br /> ➣ F. Hoffmann La Roche Ltd.<br /> ➣ GlaxoSmithKline Plc<br /> ➣ Merck and Co. Inc.<br /> ➣ Novartis AG<br /> ➣ PerkinElmer Inc<br /> ➣ Pfizer Inc.<br /> ➣ Puma Biotechnology Inc.<br /> ➣ Sanofi SA<br /> ➣ Teva Pharmaceutical Industries Ltd.<br /> ➣ Viatris Inc. </li> </ul> <p>ã¾ãŸã€æœ¬ãƒ¬ãƒãƒ¼ãƒˆã«ã¯ã€å¸‚å ´ã®æˆé•·ã«å½±éŸ¿ã‚’与ãˆã‚‹ä»Šå¾Œã®å‚¾å‘ã¨èª²é¡Œã«é–¢ã™ã‚‹æƒ…å ±ãŒå«ã¾ã‚Œã¦ã„ã¾ã™ã€‚ã“ã‚Œã¯ã€ä¼æ¥ãŒä»Šå¾Œã®ã™ã¹ã¦ã®æˆé•·æ©Ÿä¼šã‚’戦略化ã—ã€æ´»ç”¨ã™ã‚‹ã®ã«å½¹ç«‹ã¡ã¾ã™ã€‚</p> <p> ã“ã®èª¿æŸ»ã¯ã€æ¥ç•Œã®ä¸»è¦å‚åŠ è€…ã‹ã‚‰ã®æ„見をå«ã‚€ä¸€æ¬¡æƒ…å ±ã¨äºŒæ¬¡æƒ…å ±ã‚’å®¢è¦³çš„ã«çµ„ã¿åˆã‚ã›ã¦å®Ÿæ–½ã•ã‚Œã¾ã—ãŸã€‚ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã«ã¯ã€ä¸»è¦ãƒ™ãƒ³ãƒ€ãƒ¼ã®åˆ†æžã«åŠ ãˆã¦ã€åŒ…括的ãªå¸‚å ´ã¨ãƒ™ãƒ³ãƒ€ãƒ¼ã®çŠ¶æ³ãŒå«ã¾ã‚Œã¦ã„ã¾ã™ã€‚ </p> <p> ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã¯ã€åˆ©ç›Šã€ä¾¡æ ¼è¨å®šã€ç«¶äº‰ã€ãƒ—ãƒãƒ¢ãƒ¼ã‚·ãƒ§ãƒ³ãªã©ã®ä¸»è¦ãªãƒ‘ラメーターã®åˆ†æžã«ã‚ˆã‚‹è¤‡æ•°ã®ã‚½ãƒ¼ã‚¹ã‹ã‚‰ã®ãƒ‡ãƒ¼ã‚¿ã®èª¿æŸ»ã€åˆæˆã€åˆè¨ˆã«ã‚ˆã‚Šã€å¸‚å ´ã®è©³ç´°ãªå…¨ä½“åƒã‚’æ示ã—ã¾ã™ã€‚æ¥ç•Œã®ä¸»è¦ãªå½±éŸ¿åŠ›ã‚’æŒã¤ä¼æ¥ã‚’特定ã™ã‚‹ã“ã¨ã§ã€ã•ã¾ã–ã¾ãªå¸‚å ´ã®å´é¢ã‚’示ã—ã¾ã™ã€‚æ示ã•ã‚ŒãŸãƒ‡ãƒ¼ã‚¿ã¯åŒ…括的ã§ä¿¡é ¼æ€§ãŒé«˜ãã€ä¸€æ¬¡ãŠã‚ˆã³äºŒæ¬¡ã®ä¸¡æ–¹ã«ã‚ãŸã‚‹åºƒç¯„ãªç ”究ã®çµæžœã§ã™ã€‚å¸‚å ´èª¿æŸ»ãƒ¬ãƒãƒ¼ãƒˆã¯ã€æ£ç¢ºãªå¸‚å ´ã®æˆé•·ã‚’予測ã™ã‚‹ãŸã‚ã®å®šæ€§çš„ãŠã‚ˆã³å®šé‡çš„調査を使用ã—ãŸã€å®Œå…¨ãªç«¶äº‰çŠ¶æ³ã¨è©³ç´°ãªãƒ™ãƒ³ãƒ€ãƒ¼é¸æŠžæ–¹æ³•è«–ãŠã‚ˆã³åˆ†æžã‚’æä¾›ã—ã¾ã™ã€‚ </p> ', 'memo' => '', 'catalog_copy' => '', 'pamphlet_pdf' => '0', 's_upload' => null, 'i_upload' => '1', 'update_flag' => null, 'update_date' => '2024-03-06 16:56:52', 'regist_date' => '0000-00-00 00:00:00' ), 'session_carts' => array(), 'id' => null, 'checked_reports' => array(), 'category_list' => array( (int) 1 => array( (int) 1 => array( [maximum depth reached] ), (int) 2 => array( [maximum depth reached] ), (int) 3 => array( [maximum depth reached] ), (int) 4 => array( [maximum depth reached] ), (int) 5 => array( [maximum depth reached] ), (int) 6 => array( [maximum depth reached] ), (int) 7 => array( [maximum depth reached] ), (int) 8 => array( [maximum depth reached] ), (int) 9 => array( [maximum depth reached] ) ), (int) 2 => array( (int) 1 => array( [maximum depth reached] ), (int) 2 => array( [maximum depth reached] ), (int) 3 => array( [maximum depth reached] ), (int) 4 => array( [maximum depth reached] ), (int) 5 => array( [maximum depth reached] ), (int) 6 => array( [maximum depth reached] ), (int) 7 => array( [maximum depth reached] ), (int) 8 => array( [maximum depth reached] ), (int) 9 => array( [maximum depth reached] ), (int) 10 => array( [maximum depth reached] ) ), (int) 3 => array( (int) 1 => array( [maximum depth reached] ), (int) 2 => array( [maximum depth reached] ), (int) 3 => array( [maximum depth reached] ), (int) 4 => array( [maximum depth reached] ), (int) 5 => array( [maximum depth reached] ), (int) 6 => array( [maximum depth reached] ) ), (int) 4 => array( (int) 1 => array( [maximum depth reached] ), (int) 2 => array( [maximum depth reached] ) ), (int) 5 => array( (int) 1 => array( [maximum depth reached] ), (int) 2 => array( [maximum depth reached] ), (int) 3 => array( [maximum depth reached] ), (int) 4 => array( [maximum depth reached] ), (int) 5 => array( [maximum depth reached] ), (int) 6 => array( [maximum depth reached] ), (int) 7 => array( [maximum depth reached] ) ), (int) 6 => array( (int) 1 => array( [maximum depth reached] ), (int) 2 => array( [maximum depth reached] ), (int) 3 => array( [maximum depth reached] ), (int) 4 => array( [maximum depth reached] ) ) ), 'category_sub_list' => array( (int) 0 => array( 'CategoryMain' => array( [maximum depth reached] ), 'CategorySub' => array( [maximum depth reached] ) ), (int) 1 => array( 'CategoryMain' => array( [maximum depth reached] ), 'CategorySub' => array( [maximum depth reached] ) ), (int) 2 => array( 'CategoryMain' => array( [maximum depth reached] ), 'CategorySub' => array( [maximum depth reached] ) ), (int) 3 => array( 'CategoryMain' => array( [maximum depth reached] ), 'CategorySub' => array( [maximum depth reached] ) ), (int) 4 => array( 'CategoryMain' => array( [maximum depth reached] ), 'CategorySub' => array( [maximum depth reached] ) ), (int) 5 => array( 'CategoryMain' => array( [maximum depth reached] ), 'CategorySub' => array( [maximum depth reached] ) ) ), 'category_main_list' => array( (int) 1 => 'エレクトãƒãƒ‹ã‚¯ã‚¹ãƒ»IT', (int) 2 => 'メディカル・ãƒã‚¤ã‚ª', (int) 3 => 'ウエルãƒã‚¹', (int) 4 => '医療IT', (int) 5 => 'エãƒãƒ«ã‚®ãƒ¼ãƒ»ç’°å¢ƒ', (int) 6 => 'ビジãƒã‚¹ä¸€èˆ¬ãƒ»ãã®ä»–' ), 'tax' => '0.1', 'content_for_layout' => ' <style type="text/css"> @media screen and (min-width: 980px) { .report_patarn_license{ display:flex; } } .report_discription p { margin-bottom:10px; } .report_discription .details { margin-bottom:20px; } .report_discription .details h4 { padding:10px 0px; font-size:18px; border-top:1px solid #666; border-bottom:1px solid #666; margin:0px 0px 10px 0px; } .report_discription .details table { border-collapse:collapse; border-spacing:0px; width:100%; } .report_discription .details table th { background-color: #006dc3; background-color:lightblue; } .report_discription .details table th, .report_discription .details table td { /*border:1px solid #999; padding:5px;*/ /*border:none;*/ } /* table th,table td{ border:1px solid #999; padding:5px; } */ .report_discription .details .mu_table th, .report_discription .details .mu_table td { /*border:1px solid #999; padding:5px;*/ border:none; } .tooltip_favorite { position:absolute; left :800px; margin : 5px; display: inline-block; text-align: center; min-width: 120px; max-width: 100%; color: #006dc3; font-size: 16px; background: #fff; border : solid 1px; border-color : #005bb8; border-radius: 30px; } .sample_report{ border: none; background-color: transparent; font-size: 15px; color:#299cbd; cursor:pointer } .license_table{ empty-cells: show; border-right:1px solid #ccc; font-size:16px; margin:5px 5px; } .license_td{ text-align:center; vertical-align: middle; color:#fff; border-bottom:1px solid #ccc; background-color:#006dc3; border-bottom:1px solid #ccc; border-left:1px solid #ccc; border:1; height:50px; width:200px; font-size:15px; } .price_td{ text-align:center; vertical-align: middle; background-color:#fff; border-bottom:1px solid #ccc; border-right:1px solid #ccc; border:1; height:50px; width:200px; font-size:17px; } .format_td{ text-align:center; vertical-align: middle; background-color:#006dc3; border-bottom:1px solid #ccc; border-right:1px solid #ccc; border:1; height:50px; width:200px; font-size:17px; color:white; } .btn_cart_div{ display:flex; text-align:center; -webkit-justify-content: center; margin:20px 0px; padding:0px 50px; } </style> <div class="breadcrumb clearfix"> <ul> <li class="home"><a href="/">ホーム</a></li> <li><a href="/categories/index/?m_id=2">メディカル・ãƒã‚¤ã‚ª</a></li> <li>ä¹³ãŒã‚“治療薬ã®ä¸–ç•Œå¸‚å ´ï¼ˆ2024-2028）</li> </ul> </div><!--/breadcrumb--> <div class="detail_main"> <form action="/categories/detail/37546?url=categories%2Fdetail%2F37546" id="detailForm" method="post" accept-charset="utf-8"><div style="display:none;"><input type="hidden" name="_method" value="POST"/></div> <div class="detail_mainIn"> <div class="detail_main_box"> <p class="report_number">レãƒãƒ¼ãƒˆãƒŠãƒ³ãƒãƒ¼ã€€0000037546</p> <div class="category"><a href="/categories/index/?m_id=2&s_id=1">医薬å“原料・製剤</a></div> <div class="category"><a href="/categories/index/?m_id=2&s_id=2">創薬一般</a></div> <div class="category"><a href="/categories/index/?m_id=2&s_id=3">ç–¾ç—…åˆ¥æ²»ç™‚ãƒ»é ˜åŸŸåˆ¥æ²»ç™‚</a></div> <h3>ä¹³ãŒã‚“治療薬ã®ä¸–ç•Œå¸‚å ´ï¼ˆ2024-2028）</h3> <p class="company">TechNavio</p> <p class="subTitle"></p> <p class="subTitle"></p> <p class="subTitle">Global Breast Cancer Therapeutics Market 2024-2028</p> <div class="data"> <p><span>発刊日</span> 2024/01/18</p> <p><span>言語</span>英語</p> <p><span>体è£</span>PDF/168ページ</p> </div> </div><!--/detail_main_box--> <div class="detail_cart_area"> <div class="report_patarn clearfix"> <p class="report_patarnIn">ライセンス/ä¾¡æ ¼<span>168ページ</span></p> <p class="report_sub_number"> 0000037546 </p> </div> <div class="report_patarn_license clearfix"> <!--<p class="license_text"> ä¹³ãŒã‚“治療薬ã®ä¸–ç•Œå¸‚å ´ï¼ˆ2024-2028）<br> Global Breast Cancer Therapeutics Market 2024-2028 </p>--> <div class= "cart_div"> <table border=1 class="license_table"><!--<p class="license_price">--> <tbody> <!--<tr> <td class="license_td"> Single </td> <td class="license_td"> Enterprise </td> </tr>--> <tr> <th class="license_td"> Single </th> <td class="price_td"> <input type="radio" name="data[ReportBase][license]" class="license_radio" id="license" value="1" checked/> <label for="license">2,500USD</label><br> </td> </tr> <tr> <th class="license_td"> Enterprise </th> <td class="price_td"> <input type="radio" name="data[ReportBase][license]" class="license_radio" id="license2" value="2" /> <label for="license2">4,000USD</label><br> </td> </tr> </tr> </tr> </tr> </tr> </tr> </tr> </tbody> </table><!--</p>--> </div> <div class="btn_cart_div"> <div class="btn_cart"> <input type="hidden" name="data[carts]" value="37546" id="carts"/> <button name="carts_add" id="carts_add">カートã¸</button> </div><!--/btn_cart--> <div class="btn_cart"> <input type="hidden" name="data[carts]" value="37546" id="carts"/> <button name="carts_now" id="carts_now">今ã™ã購入</button> </div><!--/btn_cart--> </div><!--/cart_div--> </div> </div><!--/detail_cart_area--> <p>※ã”請求ã¯ã€ãŠç”³è¾¼æ—¥ã®TTSレートã§å††æ›ç®—ã—ã€æ¶ˆè²»ç¨Žã‚’åŠ ãˆãŸé‡‘é¡ã«ãªã‚Šã¾ã™ã€‚<br />※本レãƒãƒ¼ãƒˆã¯ã€è‹±æ–‡ã§ã™ã€‚PDF(é›»å媒体)ã§ã®ç´å“ã¨ãªã‚Šã¾ã™ã€‚<br />※本レãƒãƒ¼ãƒˆã¯å–り寄ã›ã¨ãªã‚Šã¾ã™ã®ã§ã€ç”³ã—è¾¼ã¿ã‹ã‚‰ãŠå±Šã‘ã¾ã§ã€å¤šå°‘時間ãŒæŽ›ã‹ã‚‹å ´åˆãŒã”ã–ã„ã¾ã™ã€‚</p> <div class="btn_report_set"> <div class="btn01" style="margin:0px auto;"> <!--<button type="submit" class="contact" value="product_id">商å“ã‚’å•ã„åˆã‚ã›ã‚‹</button>--> <a href="https://www.spi-information.com/contacts/report_contact?report=37546&sample=0">ãŠå•ã„åˆã‚ã›</a> </div> <div class="btn01" style="margin:0px auto;"><a href="https://www.spi-information.com/contacts/report_contact?report=37546&sample=1">サンプルä¾é ¼</a></div> <button class="btn-form-cart" name="estimate" value="1">見ç©æ›¸ä½œæˆ</button> </div><!--/btn_report_set--> <div class="sample_box"> <p>無料サンプル</p> <ul> <li>サンプルã¯ãŠå•ã„åˆã‚ã›ãã ã•ã„。</li> </ul> </div><!--/sample_box--> <div class="report_discription"> <h3>レãƒãƒ¼ãƒˆæ¦‚è¦</h3> <p> ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã¯2023å¹´ã‹ã‚‰2028å¹´ã«156å„„4,000万米ドルã€äºˆæ¸¬æœŸé–“ä¸ã®CAGRã¯8.4%ã§æˆé•·ã™ã‚‹ã¨äºˆæ¸¬ã•ã‚Œã¾ã™ã€‚ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã¯ã€å…¨ä½“çš„ãªåˆ†æžã€å¸‚å ´è¦æ¨¡ã¨äºˆæ¸¬ã€å‚¾å‘ã€æˆé•·ãƒ‰ãƒ©ã‚¤ãƒãƒ¼ã€èª²é¡Œã€ãŠã‚ˆã³ç´„25ã®ãƒ™ãƒ³ãƒ€ãƒ¼ã‚’ã‚«ãƒãƒ¼ã™ã‚‹ãƒ™ãƒ³ãƒ€ãƒ¼åˆ†æžã‚’æä¾›ã—ã¾ã™ã€‚ </p> <p> ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã¯ã€ç¾åœ¨ã®å¸‚å ´ã‚·ãƒŠãƒªã‚ªã€æœ€æ–°ã®å‚¾å‘ã¨æŽ¨é€²åŠ›ã€ãŠã‚ˆã³å…¨ä½“çš„ãªå¸‚å ´ç’°å¢ƒã«é–¢ã™ã‚‹æœ€æ–°ã®åˆ†æžã‚’æä¾›ã—ã¾ã™ã€‚ä¹³ãŒã‚“罹患率ã®ä¸Šæ˜‡ã€å …調ãªãƒ‘イプラインã¨æ–°è–¬æ‰¿èªã€æ‚£è€…を支æ´ã™ã‚‹å–り組ã¿ã®å¢—åŠ ãªã©ãŒå¸‚å ´ã‚’ç‰½å¼•ã—ã¦ã„ã¾ã™ã€‚ </p> <p> <span style="font-weight:bold;">調査範囲</span> </p> <ul class="rfp_mar-b1"> <li> <span style="font-weight:bold;">å¸‚å ´ã‚»ã‚°ãƒ¡ãƒ³ãƒˆ</span> <br /> <span style="font-weight:bold;">➣ 疾患タイプ別</span> <br /> 　　◇ 浸潤性乳ãŒã‚“<br /> 　　◇ éžæµ¸æ½¤æ€§ä¹³ãŒã‚“（DCIS）<br /> <span style="font-weight:bold;">➣ セラピー別</span> <br /> 　　◇ 標的療法<br /> 　　◇ ホルモン療法<br /> 　　◇ 化å¦ç™‚法<br /> <span style="font-weight:bold;">➣ 地域別</span> <br /> 　　◇ 北アメリカ<br /> 　　◇ ヨーãƒãƒƒãƒ‘<br /> 　　◇ アジア<br /> 　　◇ 世界ã®ãã®ä»–ã®åœ°åŸŸï¼ˆROW） </li> </ul> <p> 本調査ã§ã¯ã€ä»Šå¾Œæ•°å¹´é–“ã®ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®æˆé•·ã‚’牽引ã™ã‚‹ä¸»ãªè¦å› ã®1ã¤ã¨ã—ã¦ã€æ–°ãŸãªæ–°è¦æ²»ç™‚薬を挙ã’ã¦ã„ã¾ã™ã€‚ã¾ãŸã€æ”¹å–„ã•ã‚ŒãŸè¨ºæ–モダリティã®åˆ©ç”¨å¯èƒ½æ€§ã‚„戦略的ææºã®å¢—åŠ ã¯ã€å¸‚å ´ã®å¤§ããªéœ€è¦ã«ã¤ãªãŒã£ã¦ã„ã¾ã™ã€‚ </p> <p>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã«é–¢ã™ã‚‹ãƒ¬ãƒãƒ¼ãƒˆã¯ã€æ¬¡ã®åˆ†é‡Žã‚’ã‚«ãƒãƒ¼ã—ã¦ã„ã¾ã™ã€‚</p> <ul class="rfp_mar-b1"> <li>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®è¦æ¨¡</li> <li>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®äºˆæ¸¬</li> <li>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®æ¥ç•Œåˆ†æž</li> </ul> <p>å …ç‰¢ãªãƒ™ãƒ³ãƒ€ãƒ¼åˆ†æžã¯ã€ã‚¯ãƒ©ã‚¤ã‚¢ãƒ³ãƒˆãŒå¸‚å ´ã§ã®åœ°ä½ã‚’å‘上ã•ã›ã‚‹ã®ã«å½¹ç«‹ã¤ã‚ˆã†ã«è¨è¨ˆã•ã‚Œã¦ã„ã¾ã™ã€‚</p> <ul class="rfp_mar-b1"> <li> <span style="font-weight:bold;">調査ä¼æ¥</span> <br /> ➣ AbbVie Inc.<br /> ➣ Amgen Inc.<br /> ➣ AstraZeneca Plc<br /> ➣ Bristol Myers Squibb Co.<br /> ➣ Clovis Oncology Inc.<br /> ➣ 第一三共（Daiichi Sankyo Co. Ltd.）<br /> ➣ エーザイ（Eisai Co. Ltd.）<br /> ➣ Eli Lilly and Co.<br /> ➣ Exelixis Inc.<br /> ➣ F. Hoffmann La Roche Ltd.<br /> ➣ GlaxoSmithKline Plc<br /> ➣ Merck and Co. Inc.<br /> ➣ Novartis AG<br /> ➣ PerkinElmer Inc<br /> ➣ Pfizer Inc.<br /> ➣ Puma Biotechnology Inc.<br /> ➣ Sanofi SA<br /> ➣ Teva Pharmaceutical Industries Ltd.<br /> ➣ Viatris Inc. </li> </ul> <p>ã¾ãŸã€æœ¬ãƒ¬ãƒãƒ¼ãƒˆã«ã¯ã€å¸‚å ´ã®æˆé•·ã«å½±éŸ¿ã‚’与ãˆã‚‹ä»Šå¾Œã®å‚¾å‘ã¨èª²é¡Œã«é–¢ã™ã‚‹æƒ…å ±ãŒå«ã¾ã‚Œã¦ã„ã¾ã™ã€‚ã“ã‚Œã¯ã€ä¼æ¥ãŒä»Šå¾Œã®ã™ã¹ã¦ã®æˆé•·æ©Ÿä¼šã‚’戦略化ã—ã€æ´»ç”¨ã™ã‚‹ã®ã«å½¹ç«‹ã¡ã¾ã™ã€‚</p> <p> ã“ã®èª¿æŸ»ã¯ã€æ¥ç•Œã®ä¸»è¦å‚åŠ è€…ã‹ã‚‰ã®æ„見をå«ã‚€ä¸€æ¬¡æƒ…å ±ã¨äºŒæ¬¡æƒ…å ±ã‚’å®¢è¦³çš„ã«çµ„ã¿åˆã‚ã›ã¦å®Ÿæ–½ã•ã‚Œã¾ã—ãŸã€‚ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã«ã¯ã€ä¸»è¦ãƒ™ãƒ³ãƒ€ãƒ¼ã®åˆ†æžã«åŠ ãˆã¦ã€åŒ…括的ãªå¸‚å ´ã¨ãƒ™ãƒ³ãƒ€ãƒ¼ã®çŠ¶æ³ãŒå«ã¾ã‚Œã¦ã„ã¾ã™ã€‚ </p> <p> ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã¯ã€åˆ©ç›Šã€ä¾¡æ ¼è¨å®šã€ç«¶äº‰ã€ãƒ—ãƒãƒ¢ãƒ¼ã‚·ãƒ§ãƒ³ãªã©ã®ä¸»è¦ãªãƒ‘ラメーターã®åˆ†æžã«ã‚ˆã‚‹è¤‡æ•°ã®ã‚½ãƒ¼ã‚¹ã‹ã‚‰ã®ãƒ‡ãƒ¼ã‚¿ã®èª¿æŸ»ã€åˆæˆã€åˆè¨ˆã«ã‚ˆã‚Šã€å¸‚å ´ã®è©³ç´°ãªå…¨ä½“åƒã‚’æ示ã—ã¾ã™ã€‚æ¥ç•Œã®ä¸»è¦ãªå½±éŸ¿åŠ›ã‚’æŒã¤ä¼æ¥ã‚’特定ã™ã‚‹ã“ã¨ã§ã€ã•ã¾ã–ã¾ãªå¸‚å ´ã®å´é¢ã‚’示ã—ã¾ã™ã€‚æ示ã•ã‚ŒãŸãƒ‡ãƒ¼ã‚¿ã¯åŒ…括的ã§ä¿¡é ¼æ€§ãŒé«˜ãã€ä¸€æ¬¡ãŠã‚ˆã³äºŒæ¬¡ã®ä¸¡æ–¹ã«ã‚ãŸã‚‹åºƒç¯„ãªç ”究ã®çµæžœã§ã™ã€‚å¸‚å ´èª¿æŸ»ãƒ¬ãƒãƒ¼ãƒˆã¯ã€æ£ç¢ºãªå¸‚å ´ã®æˆé•·ã‚’予測ã™ã‚‹ãŸã‚ã®å®šæ€§çš„ãŠã‚ˆã³å®šé‡çš„調査を使用ã—ãŸã€å®Œå…¨ãªç«¶äº‰çŠ¶æ³ã¨è©³ç´°ãªãƒ™ãƒ³ãƒ€ãƒ¼é¸æŠžæ–¹æ³•è«–ãŠã‚ˆã³åˆ†æžã‚’æä¾›ã—ã¾ã™ã€‚ </p> <h3>レãƒãƒ¼ãƒˆè©³ç´°</h3> <div class="details"> <h4>目次</h4> <p> <span style="font-weight:bold;">Table of Contents</span> </p> <p> <span style="font-weight:bold;">1 Executive Summary</span> <br /> 1.1 Market overview<br /> Exhibit 01: Executive Summary - Chart on Market Overview<br /> Exhibit 02: Executive Summary - Data Table on Market Overview<br /> Exhibit 03: Executive Summary - Chart on Global Market Characteristics<br /> Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape<br /> Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type<br /> Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapy<br /> Exhibit 07: Executive Summary - Chart on Incremental Growth<br /> Exhibit 08: Executive Summary - Data Table on Incremental Growth<br /> Exhibit 09: Executive Summary - Chart on Vendor Market Positioning </p> <p> <span style="font-weight:bold;">2 Market Landscape</span> <br /> 2.1 Market ecosystem<br /> Exhibit 10: Parent market<br /> Exhibit 11: Market Characteristics </p> <p> <span style="font-weight:bold;">3 Market Sizing</span> <br /> 3.1 Market definition<br /> Exhibit 12: Offerings of vendors included in the market definition<br /> 3.2 Market segment analysis<br /> Exhibit 13: Market segments<br /> 3.3 Market size 2023<br /> 3.4 Market outlook: Forecast for 2023-2028<br /> Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)<br /> Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%) </p> <p> <span style="font-weight:bold;">4 Historic Market Size</span> <br /> 4.1 Global breast cancer therapeutics market 2018 - 2022<br /> Exhibit 18: Historic Market Size - Data Table on global breast cancer therapeutics market 2018 - 2022 ($ billion)<br /> 4.2 Disease Type Segment Analysis 2018 - 2022<br /> Exhibit 19: Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion)<br /> 4.3 Therapy Segment Analysis 2018 - 2022<br /> Exhibit 20: Historic Market Size - Therapy Segment 2018 - 2022 ($ billion)<br /> 4.4 Geography Segment Analysis 2018 - 2022<br /> Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)<br /> 4.5 Country Segment Analysis 2018 - 2022<br /> Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion) </p> <p> <span style="font-weight:bold;">5 Five Forces Analysis</span> <br /> 5.1 Five forces summary<br /> Exhibit 23: Five forces analysis - Comparison between 2023 and 2028<br /> 5.2 Bargaining power of buyers<br /> Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028<br /> 5.3 Bargaining power of suppliers<br /> Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028<br /> 5.4 Threat of new entrants<br /> Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028<br /> 5.5 Threat of substitutes<br /> Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028<br /> 5.6 Threat of rivalry<br /> Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028<br /> 5.7 Market condition<br /> Exhibit 29: Chart on Market condition - Five forces 2023 and 2028 </p> <p> <span style="font-weight:bold;">6 Market Segmentation by Disease Type</span> <br /> 6.1 Market segments<br /> Exhibit 30: Chart on Disease Type - Market share 2023-2028 (%)<br /> Exhibit 31: Data Table on Disease Type - Market share 2023-2028 (%)<br /> 6.2 Comparison by Disease Type<br /> Exhibit 32: Chart on Comparison by Disease Type<br /> Exhibit 33: Data Table on Comparison by Disease Type<br /> 6.3 Invasive breast cancers - Market size and forecast 2023-2028<br /> Exhibit 34: Chart on Invasive breast cancers - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 35: Data Table on Invasive breast cancers - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 36: Chart on Invasive breast cancers - Year-over-year growth 2023-2028 (%)<br /> Exhibit 37: Data Table on Invasive breast cancers - Year-over-year growth 2023-2028 (%)<br /> 6.4 Ductal carcinoma in situ - Market size and forecast 2023-2028<br /> Exhibit 38: Chart on Ductal carcinoma in situ - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 39: Data Table on Ductal carcinoma in situ - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 40: Chart on Ductal carcinoma in situ - Year-over-year growth 2023-2028 (%)<br /> Exhibit 41: Data Table on Ductal carcinoma in situ - Year-over-year growth 2023-2028 (%)<br /> 6.5 Market opportunity by Disease Type<br /> Exhibit 42: Market opportunity by Disease Type ($ billion)<br /> Exhibit 43: Data Table on Market opportunity by Disease Type ($ billion) </p> <p> <span style="font-weight:bold;">7 Market Segmentation by Therapy</span> <br /> 7.1 Market segments<br /> Exhibit 44: Chart on Therapy - Market share 2023-2028 (%)<br /> Exhibit 45: Data Table on Therapy - Market share 2023-2028 (%)<br /> 7.2 Comparison by Therapy<br /> Exhibit 46: Chart on Comparison by Therapy<br /> Exhibit 47: Data Table on Comparison by Therapy<br /> 7.3 Targeted therapy - Market size and forecast 2023-2028<br /> Exhibit 48: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 49: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 50: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)<br /> Exhibit 51: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)<br /> 7.4 Hormonal therapy - Market size and forecast 2023-2028<br /> Exhibit 52: Chart on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 53: Data Table on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 54: Chart on Hormonal therapy - Year-over-year growth 2023-2028 (%)<br /> Exhibit 55: Data Table on Hormonal therapy - Year-over-year growth 2023-2028 (%)<br /> 7.5 Chemotherapy - Market size and forecast 2023-2028<br /> Exhibit 56: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 57: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 58: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)<br /> Exhibit 59: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)<br /> 7.6 Market opportunity by Therapy<br /> Exhibit 60: Market opportunity by Therapy ($ billion)<br /> Exhibit 61: Data Table on Market opportunity by Therapy ($ billion) </p> <p> <span style="font-weight:bold;">8 Customer Landscape</span> <br /> 8.1 Customer landscape overview<br /> Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria </p> <p> <span style="font-weight:bold;">9 Geographic Landscape</span> <br /> 9.1 Geographic segmentation<br /> Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)<br /> Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)<br /> 9.2 Geographic comparison<br /> Exhibit 65: Chart on Geographic comparison<br /> Exhibit 66: Data Table on Geographic comparison<br /> 9.3 North America - Market size and forecast 2023-2028<br /> Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)<br /> Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)<br /> 9.4 Europe - Market size and forecast 2023-2028<br /> Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)<br /> Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)<br /> 9.5 Asia - Market size and forecast 2023-2028<br /> Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)<br /> Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)<br /> 9.6 Rest of World (ROW) - Market size and forecast 2023-2028<br /> Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)<br /> Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)<br /> 9.7 US - Market size and forecast 2023-2028<br /> Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)<br /> Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)<br /> 9.8 Germany - Market size and forecast 2023-2028<br /> Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)<br /> Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)<br /> 9.9 Canada - Market size and forecast 2023-2028<br /> Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)<br /> Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)<br /> 9.10 UK - Market size and forecast 2023-2028<br /> Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)<br /> Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)<br /> 9.11 China - Market size and forecast 2023-2028<br /> Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)<br /> Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)<br /> 9.12 Market opportunity By Geographical Landscape<br /> Exhibit 103: Market opportunity By Geographical Landscape ($ billion)<br /> Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion) </p> <p> <span style="font-weight:bold;">10 Drivers, Challenges, and Trends</span> <br /> 10.1 Market drivers<br /> 10.2 Market challenges<br /> 10.3 Impact of drivers and challenges<br /> Exhibit 105: Impact of drivers and challenges in 2023 and 2028<br /> 10.4 Market trends </p> <p> <span style="font-weight:bold;">11 Vendor Landscape</span> <br /> 11.1 Overview<br /> 11.2 Vendor landscape<br /> Exhibit 106: Overview on Criticality of inputs and Factors of differentiation<br /> 11.3 Landscape disruption<br /> Exhibit 107: Overview on factors of disruption<br /> 11.4 Industry risks<br /> Exhibit 108: Impact of key risks on business </p> <p> <span style="font-weight:bold;">12 Vendor Analysis</span> <br /> 12.1 Vendors covered<br /> Exhibit 109: Vendors covered<br /> 12.2 Market positioning of vendors<br /> Exhibit 110: Matrix on vendor position and classification<br /> 12.3 AbbVie Inc.<br /> Exhibit 111: AbbVie Inc. - Overview<br /> Exhibit 112: AbbVie Inc. - Product / Service<br /> Exhibit 113: AbbVie Inc. - Key news<br /> Exhibit 114: AbbVie Inc. - Key offerings<br /> 12.4 Amgen Inc.<br /> Exhibit 115: Amgen Inc. - Overview<br /> Exhibit 116: Amgen Inc. - Product / Service<br /> Exhibit 117: Amgen Inc. - Key offerings<br /> 12.5 AstraZeneca Plc<br /> Exhibit 118: AstraZeneca Plc - Overview<br /> Exhibit 119: AstraZeneca Plc - Product / Service<br /> Exhibit 120: AstraZeneca Plc - Key news<br /> Exhibit 121: AstraZeneca Plc - Key offerings<br /> 12.6 Bristol Myers Squibb Co.<br /> Exhibit 122: Bristol Myers Squibb Co. - Overview<br /> Exhibit 123: Bristol Myers Squibb Co. - Product / Service<br /> Exhibit 124: Bristol Myers Squibb Co. - Key news<br /> Exhibit 125: Bristol Myers Squibb Co. - Key offerings<br /> 12.7 Clovis Oncology Inc.<br /> Exhibit 126: Clovis Oncology Inc. - Overview<br /> Exhibit 127: Clovis Oncology Inc. - Product / Service<br /> Exhibit 128: Clovis Oncology Inc. - Key offerings<br /> 12.8 Daiichi Sankyo Co. Ltd.<br /> Exhibit 129: Daiichi Sankyo Co. Ltd. - Overview<br /> Exhibit 130: Daiichi Sankyo Co. Ltd. - Product / Service<br /> Exhibit 131: Daiichi Sankyo Co. Ltd. - Key news<br /> Exhibit 132: Daiichi Sankyo Co. Ltd. - Key offerings<br /> 12.9 Eisai Co. Ltd.<br /> Exhibit 133: Eisai Co. Ltd. - Overview<br /> Exhibit 134: Eisai Co. Ltd. - Business segments<br /> Exhibit 135: Eisai Co. Ltd. - Key offerings<br /> Exhibit 136: Eisai Co. Ltd. - Segment focus<br /> 12.10 Eli Lilly and Co.<br /> Exhibit 137: Eli Lilly and Co. - Overview<br /> Exhibit 138: Eli Lilly and Co. - Product / Service<br /> Exhibit 139: Eli Lilly and Co. - Key news<br /> Exhibit 140: Eli Lilly and Co. - Key offerings<br /> 12.11 Exelixis Inc.<br /> Exhibit 141: Exelixis Inc. - Overview<br /> Exhibit 142: Exelixis Inc. - Product / Service<br /> Exhibit 143: Exelixis Inc. - Key offerings<br /> 12.12 F. Hoffmann La Roche Ltd.<br /> Exhibit 144: F. Hoffmann La Roche Ltd. - Overview<br /> Exhibit 145: F. Hoffmann La Roche Ltd. - Business segments<br /> Exhibit 146: F. Hoffmann La Roche Ltd. - Key news<br /> Exhibit 147: F. Hoffmann La Roche Ltd. - Key offerings<br /> Exhibit 148: F. Hoffmann La Roche Ltd. - Segment focus<br /> 12.13 GlaxoSmithKline Plc<br /> Exhibit 149: GlaxoSmithKline Plc - Overview<br /> Exhibit 150: GlaxoSmithKline Plc - Business segments<br /> Exhibit 151: GlaxoSmithKline Plc - Key news<br /> Exhibit 152: GlaxoSmithKline Plc - Key offerings<br /> Exhibit 153: GlaxoSmithKline Plc - Segment focus<br /> 12.14 Merck and Co. Inc.<br /> Exhibit 154: Merck and Co. Inc. - Overview<br /> Exhibit 155: Merck and Co. Inc. - Business segments<br /> Exhibit 156: Merck and Co. Inc. - Key news<br /> Exhibit 157: Merck and Co. Inc. - Key offerings<br /> Exhibit 158: Merck and Co. Inc. - Segment focus<br /> 12.15 Novartis AG<br /> Exhibit 159: Novartis AG - Overview<br /> Exhibit 160: Novartis AG - Business segments<br /> Exhibit 161: Novartis AG - Key offerings<br /> Exhibit 162: Novartis AG - Segment focus<br /> 12.16 Pfizer Inc.<br /> Exhibit 163: Pfizer Inc. - Overview<br /> Exhibit 164: Pfizer Inc. - Product / Service<br /> Exhibit 165: Pfizer Inc. - Key news<br /> Exhibit 166: Pfizer Inc. - Key offerings<br /> 12.17 Viatris Inc.<br /> Exhibit 167: Viatris Inc. - Overview<br /> Exhibit 168: Viatris Inc. - Business segments<br /> Exhibit 169: Viatris Inc. - Key news<br /> Exhibit 170: Viatris Inc. - Key offerings<br /> Exhibit 171: Viatris Inc. - Segment focus </p> <p> <span style="font-weight:bold;">13 Appendix</span> <br /> 13.1 Scope of the report<br /> 13.2 Inclusions and exclusions checklist<br /> Exhibit 172: Inclusions checklist<br /> Exhibit 173: Exclusions checklist<br /> 13.3 Currency conversion rates for US$<br /> Exhibit 174: Currency conversion rates for US$<br /> 13.4 Research methodology<br /> Exhibit 175: Research methodology<br /> Exhibit 176: Validation techniques employed for market sizing<br /> Exhibit 177: Information sources<br /> 13.5 List of abbreviations<br /> Exhibit 178: List of abbreviations </p> </div> </div><!--/report_discription--> <div class="btn_report_set"> <div class="btn01"> <a href="/guides">ãŠè²·ã„物ガイド</a> </div><!--/btn01--> <div class="btn01"> <a href="/questions">よãã‚る質å•</a> </div><!--/btn01--> </div><!--/btn_report_set--> <div class="tel_guide clearfix"> <a href="tel:0358125270"><img src="/img/./category/suport_tel_03.jpg" alt=""/></a> <div class="report_no"> <p>ã“ã®å•†å“ã®ãƒ¬ãƒãƒ¼ãƒˆãƒŠãƒ³ãƒãƒ¼</p> <p class="report_no_box">0000037546</p> </div> </div><!--/tel_guide--> </div> </form> </div> <script type="text/javascript"> $('#carts_add').css("cursor","pointer"); $('#carts_now').css("cursor","pointer"); $('#heart_off').css("cursor","pointer"); $('.heart_off').css("cursor","pointer"); $(function(){ if($('#stlist').length){ $('.btn_cart').fadeOut(); } }); $(function () { $('.tooltip_favorite').hide(); $('div').hover( function () { $(this).children('.tooltip_favorite').fadeIn('fast'); }, function () { $(this).children('.tooltip_favorite').fadeOut('fast'); }); }); </script> ', 'scripts_for_layout' => '', 'title_for_layout' => 'Categories' ) $favorite_data = array() $keywords = array( (int) 0 => 'ä¹³ãŒã‚“治療薬', (int) 1 => '標的療法', (int) 2 => 'ホルモン療法', (int) 3 => '化å¦ç™‚法', (int) 4 => '女性ã®å¥åº·' ) $summary = array() $rrc = array( (int) 0 => array( 'ReportRelationCategory' => array( 'id' => '64202', 'report_id' => '37546', 'category_id' => '2', 'subcategory_id' => '1', 'old_category_id' => null, 'old_subcategory_id' => null, 'update_date' => '2024-03-06 16:56:52' ) ), (int) 1 => array( 'ReportRelationCategory' => array( 'id' => '64203', 'report_id' => '37546', 'category_id' => '2', 'subcategory_id' => '2', 'old_category_id' => null, 'old_subcategory_id' => null, 'update_date' => '2024-03-06 16:56:52' ) ), (int) 2 => array( 'ReportRelationCategory' => array( 'id' => '64204', 'report_id' => '37546', 'category_id' => '2', 'subcategory_id' => '3', 'old_category_id' => null, 'old_subcategory_id' => null, 'update_date' => '2024-03-06 16:56:52' ) ) ) $rrr_report_base_res = array() $report_detail = array( (int) 0 => array( 'id' => '45243', 'order_num' => '1', 'report_id' => '37546', 'title' => '目次', 'body' => '<p> <span style="font-weight:bold;">Table of Contents</span> </p> <p> <span style="font-weight:bold;">1 Executive Summary</span> <br /> 1.1 Market overview<br /> Exhibit 01: Executive Summary - Chart on Market Overview<br /> Exhibit 02: Executive Summary - Data Table on Market Overview<br /> Exhibit 03: Executive Summary - Chart on Global Market Characteristics<br /> Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape<br /> Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type<br /> Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapy<br /> Exhibit 07: Executive Summary - Chart on Incremental Growth<br /> Exhibit 08: Executive Summary - Data Table on Incremental Growth<br /> Exhibit 09: Executive Summary - Chart on Vendor Market Positioning </p> <p> <span style="font-weight:bold;">2 Market Landscape</span> <br /> 2.1 Market ecosystem<br /> Exhibit 10: Parent market<br /> Exhibit 11: Market Characteristics </p> <p> <span style="font-weight:bold;">3 Market Sizing</span> <br /> 3.1 Market definition<br /> Exhibit 12: Offerings of vendors included in the market definition<br /> 3.2 Market segment analysis<br /> Exhibit 13: Market segments<br /> 3.3 Market size 2023<br /> 3.4 Market outlook: Forecast for 2023-2028<br /> Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)<br /> Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%) </p> <p> <span style="font-weight:bold;">4 Historic Market Size</span> <br /> 4.1 Global breast cancer therapeutics market 2018 - 2022<br /> Exhibit 18: Historic Market Size - Data Table on global breast cancer therapeutics market 2018 - 2022 ($ billion)<br /> 4.2 Disease Type Segment Analysis 2018 - 2022<br /> Exhibit 19: Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion)<br /> 4.3 Therapy Segment Analysis 2018 - 2022<br /> Exhibit 20: Historic Market Size - Therapy Segment 2018 - 2022 ($ billion)<br /> 4.4 Geography Segment Analysis 2018 - 2022<br /> Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)<br /> 4.5 Country Segment Analysis 2018 - 2022<br /> Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion) </p> <p> <span style="font-weight:bold;">5 Five Forces Analysis</span> <br /> 5.1 Five forces summary<br /> Exhibit 23: Five forces analysis - Comparison between 2023 and 2028<br /> 5.2 Bargaining power of buyers<br /> Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028<br /> 5.3 Bargaining power of suppliers<br /> Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028<br /> 5.4 Threat of new entrants<br /> Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028<br /> 5.5 Threat of substitutes<br /> Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028<br /> 5.6 Threat of rivalry<br /> Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028<br /> 5.7 Market condition<br /> Exhibit 29: Chart on Market condition - Five forces 2023 and 2028 </p> <p> <span style="font-weight:bold;">6 Market Segmentation by Disease Type</span> <br /> 6.1 Market segments<br /> Exhibit 30: Chart on Disease Type - Market share 2023-2028 (%)<br /> Exhibit 31: Data Table on Disease Type - Market share 2023-2028 (%)<br /> 6.2 Comparison by Disease Type<br /> Exhibit 32: Chart on Comparison by Disease Type<br /> Exhibit 33: Data Table on Comparison by Disease Type<br /> 6.3 Invasive breast cancers - Market size and forecast 2023-2028<br /> Exhibit 34: Chart on Invasive breast cancers - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 35: Data Table on Invasive breast cancers - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 36: Chart on Invasive breast cancers - Year-over-year growth 2023-2028 (%)<br /> Exhibit 37: Data Table on Invasive breast cancers - Year-over-year growth 2023-2028 (%)<br /> 6.4 Ductal carcinoma in situ - Market size and forecast 2023-2028<br /> Exhibit 38: Chart on Ductal carcinoma in situ - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 39: Data Table on Ductal carcinoma in situ - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 40: Chart on Ductal carcinoma in situ - Year-over-year growth 2023-2028 (%)<br /> Exhibit 41: Data Table on Ductal carcinoma in situ - Year-over-year growth 2023-2028 (%)<br /> 6.5 Market opportunity by Disease Type<br /> Exhibit 42: Market opportunity by Disease Type ($ billion)<br /> Exhibit 43: Data Table on Market opportunity by Disease Type ($ billion) </p> <p> <span style="font-weight:bold;">7 Market Segmentation by Therapy</span> <br /> 7.1 Market segments<br /> Exhibit 44: Chart on Therapy - Market share 2023-2028 (%)<br /> Exhibit 45: Data Table on Therapy - Market share 2023-2028 (%)<br /> 7.2 Comparison by Therapy<br /> Exhibit 46: Chart on Comparison by Therapy<br /> Exhibit 47: Data Table on Comparison by Therapy<br /> 7.3 Targeted therapy - Market size and forecast 2023-2028<br /> Exhibit 48: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 49: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 50: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)<br /> Exhibit 51: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)<br /> 7.4 Hormonal therapy - Market size and forecast 2023-2028<br /> Exhibit 52: Chart on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 53: Data Table on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 54: Chart on Hormonal therapy - Year-over-year growth 2023-2028 (%)<br /> Exhibit 55: Data Table on Hormonal therapy - Year-over-year growth 2023-2028 (%)<br /> 7.5 Chemotherapy - Market size and forecast 2023-2028<br /> Exhibit 56: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 57: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 58: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)<br /> Exhibit 59: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)<br /> 7.6 Market opportunity by Therapy<br /> Exhibit 60: Market opportunity by Therapy ($ billion)<br /> Exhibit 61: Data Table on Market opportunity by Therapy ($ billion) </p> <p> <span style="font-weight:bold;">8 Customer Landscape</span> <br /> 8.1 Customer landscape overview<br /> Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria </p> <p> <span style="font-weight:bold;">9 Geographic Landscape</span> <br /> 9.1 Geographic segmentation<br /> Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)<br /> Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)<br /> 9.2 Geographic comparison<br /> Exhibit 65: Chart on Geographic comparison<br /> Exhibit 66: Data Table on Geographic comparison<br /> 9.3 North America - Market size and forecast 2023-2028<br /> Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)<br /> Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)<br /> 9.4 Europe - Market size and forecast 2023-2028<br /> Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)<br /> Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)<br /> 9.5 Asia - Market size and forecast 2023-2028<br /> Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)<br /> Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)<br /> 9.6 Rest of World (ROW) - Market size and forecast 2023-2028<br /> Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)<br /> Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)<br /> 9.7 US - Market size and forecast 2023-2028<br /> Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)<br /> Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)<br /> 9.8 Germany - Market size and forecast 2023-2028<br /> Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)<br /> Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)<br /> 9.9 Canada - Market size and forecast 2023-2028<br /> Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)<br /> Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)<br /> 9.10 UK - Market size and forecast 2023-2028<br /> Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)<br /> Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)<br /> 9.11 China - Market size and forecast 2023-2028<br /> Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)<br /> Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)<br /> 9.12 Market opportunity By Geographical Landscape<br /> Exhibit 103: Market opportunity By Geographical Landscape ($ billion)<br /> Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion) </p> <p> <span style="font-weight:bold;">10 Drivers, Challenges, and Trends</span> <br /> 10.1 Market drivers<br /> 10.2 Market challenges<br /> 10.3 Impact of drivers and challenges<br /> Exhibit 105: Impact of drivers and challenges in 2023 and 2028<br /> 10.4 Market trends </p> <p> <span style="font-weight:bold;">11 Vendor Landscape</span> <br /> 11.1 Overview<br /> 11.2 Vendor landscape<br /> Exhibit 106: Overview on Criticality of inputs and Factors of differentiation<br /> 11.3 Landscape disruption<br /> Exhibit 107: Overview on factors of disruption<br /> 11.4 Industry risks<br /> Exhibit 108: Impact of key risks on business </p> <p> <span style="font-weight:bold;">12 Vendor Analysis</span> <br /> 12.1 Vendors covered<br /> Exhibit 109: Vendors covered<br /> 12.2 Market positioning of vendors<br /> Exhibit 110: Matrix on vendor position and classification<br /> 12.3 AbbVie Inc.<br /> Exhibit 111: AbbVie Inc. - Overview<br /> Exhibit 112: AbbVie Inc. - Product / Service<br /> Exhibit 113: AbbVie Inc. - Key news<br /> Exhibit 114: AbbVie Inc. - Key offerings<br /> 12.4 Amgen Inc.<br /> Exhibit 115: Amgen Inc. - Overview<br /> Exhibit 116: Amgen Inc. - Product / Service<br /> Exhibit 117: Amgen Inc. - Key offerings<br /> 12.5 AstraZeneca Plc<br /> Exhibit 118: AstraZeneca Plc - Overview<br /> Exhibit 119: AstraZeneca Plc - Product / Service<br /> Exhibit 120: AstraZeneca Plc - Key news<br /> Exhibit 121: AstraZeneca Plc - Key offerings<br /> 12.6 Bristol Myers Squibb Co.<br /> Exhibit 122: Bristol Myers Squibb Co. - Overview<br /> Exhibit 123: Bristol Myers Squibb Co. - Product / Service<br /> Exhibit 124: Bristol Myers Squibb Co. - Key news<br /> Exhibit 125: Bristol Myers Squibb Co. - Key offerings<br /> 12.7 Clovis Oncology Inc.<br /> Exhibit 126: Clovis Oncology Inc. - Overview<br /> Exhibit 127: Clovis Oncology Inc. - Product / Service<br /> Exhibit 128: Clovis Oncology Inc. - Key offerings<br /> 12.8 Daiichi Sankyo Co. Ltd.<br /> Exhibit 129: Daiichi Sankyo Co. Ltd. - Overview<br /> Exhibit 130: Daiichi Sankyo Co. Ltd. - Product / Service<br /> Exhibit 131: Daiichi Sankyo Co. Ltd. - Key news<br /> Exhibit 132: Daiichi Sankyo Co. Ltd. - Key offerings<br /> 12.9 Eisai Co. Ltd.<br /> Exhibit 133: Eisai Co. Ltd. - Overview<br /> Exhibit 134: Eisai Co. Ltd. - Business segments<br /> Exhibit 135: Eisai Co. Ltd. - Key offerings<br /> Exhibit 136: Eisai Co. Ltd. - Segment focus<br /> 12.10 Eli Lilly and Co.<br /> Exhibit 137: Eli Lilly and Co. - Overview<br /> Exhibit 138: Eli Lilly and Co. - Product / Service<br /> Exhibit 139: Eli Lilly and Co. - Key news<br /> Exhibit 140: Eli Lilly and Co. - Key offerings<br /> 12.11 Exelixis Inc.<br /> Exhibit 141: Exelixis Inc. - Overview<br /> Exhibit 142: Exelixis Inc. - Product / Service<br /> Exhibit 143: Exelixis Inc. - Key offerings<br /> 12.12 F. Hoffmann La Roche Ltd.<br /> Exhibit 144: F. Hoffmann La Roche Ltd. - Overview<br /> Exhibit 145: F. Hoffmann La Roche Ltd. - Business segments<br /> Exhibit 146: F. Hoffmann La Roche Ltd. - Key news<br /> Exhibit 147: F. Hoffmann La Roche Ltd. - Key offerings<br /> Exhibit 148: F. Hoffmann La Roche Ltd. - Segment focus<br /> 12.13 GlaxoSmithKline Plc<br /> Exhibit 149: GlaxoSmithKline Plc - Overview<br /> Exhibit 150: GlaxoSmithKline Plc - Business segments<br /> Exhibit 151: GlaxoSmithKline Plc - Key news<br /> Exhibit 152: GlaxoSmithKline Plc - Key offerings<br /> Exhibit 153: GlaxoSmithKline Plc - Segment focus<br /> 12.14 Merck and Co. Inc.<br /> Exhibit 154: Merck and Co. Inc. - Overview<br /> Exhibit 155: Merck and Co. Inc. - Business segments<br /> Exhibit 156: Merck and Co. Inc. - Key news<br /> Exhibit 157: Merck and Co. Inc. - Key offerings<br /> Exhibit 158: Merck and Co. Inc. - Segment focus<br /> 12.15 Novartis AG<br /> Exhibit 159: Novartis AG - Overview<br /> Exhibit 160: Novartis AG - Business segments<br /> Exhibit 161: Novartis AG - Key offerings<br /> Exhibit 162: Novartis AG - Segment focus<br /> 12.16 Pfizer Inc.<br /> Exhibit 163: Pfizer Inc. - Overview<br /> Exhibit 164: Pfizer Inc. - Product / Service<br /> Exhibit 165: Pfizer Inc. - Key news<br /> Exhibit 166: Pfizer Inc. - Key offerings<br /> 12.17 Viatris Inc.<br /> Exhibit 167: Viatris Inc. - Overview<br /> Exhibit 168: Viatris Inc. - Business segments<br /> Exhibit 169: Viatris Inc. - Key news<br /> Exhibit 170: Viatris Inc. - Key offerings<br /> Exhibit 171: Viatris Inc. - Segment focus </p> <p> <span style="font-weight:bold;">13 Appendix</span> <br /> 13.1 Scope of the report<br /> 13.2 Inclusions and exclusions checklist<br /> Exhibit 172: Inclusions checklist<br /> Exhibit 173: Exclusions checklist<br /> 13.3 Currency conversion rates for US$<br /> Exhibit 174: Currency conversion rates for US$<br /> 13.4 Research methodology<br /> Exhibit 175: Research methodology<br /> Exhibit 176: Validation techniques employed for market sizing<br /> Exhibit 177: Information sources<br /> 13.5 List of abbreviations<br /> Exhibit 178: List of abbreviations </p> ', 'update_date' => '2024-03-06 16:57:10' ) ) $report_pdf = array() $report_base = array( 'id' => '37546', 'pj_code' => '999999', 'title_main' => 'ä¹³ãŒã‚“治療薬ã®ä¸–ç•Œå¸‚å ´ï¼ˆ2024-2028）', 'title_volume' => '', 'title_volumetitle' => '', 'charge_person' => '37', 'subtitle' => 'Global Breast Cancer Therapeutics Market 2024-2028', 'keyword1' => 'ä¹³ãŒã‚“治療薬', 'keyword2' => '標的療法', 'keyword3' => 'ホルモン療法', 'keyword4' => '化å¦ç™‚法', 'keyword5' => '女性ã®å¥åº·', 'summary1' => '', 'summary2' => '', 'summary3' => '', 'language' => '2', 'disp_status' => '1', 'publish_status' => '1', 'publish_date' => '2024-01-18', 'publish_date_ymdsp' => false, 'publish_check' => null, 'price_reserve' => '0', 'price_reserve2' => '0', 'price_reserve3' => '0', 'price_reserve4' => '0', 'price_reserve5' => '0', 'license_reserve' => '', 'license_reserve2' => '', 'license_reserve3' => '', 'license_reserve4' => '', 'license_reserve5' => '', 'price' => '2500', 'price2' => '4000', 'price3' => '0', 'price4' => '0', 'price5' => '0', 'price6' => '0', 'price7' => '0', 'price8' => '0', 'license' => 'Single', 'license2' => 'Enterprise', 'license3' => '', 'license4' => '', 'license5' => '', 'license6' => '', 'license7' => '', 'license8' => '', 'unit_e' => null, 'unit' => 'USD', 'style_format' => 'PDF', 'about_flag' => '0', 'style_page' => '168', 'publishing_office' => 'TechNavio', 'note' => '※ã”請求ã¯ã€ãŠç”³è¾¼æ—¥ã®TTSレートã§å††æ›ç®—ã—ã€æ¶ˆè²»ç¨Žã‚’åŠ ãˆãŸé‡‘é¡ã«ãªã‚Šã¾ã™ã€‚<br />※本レãƒãƒ¼ãƒˆã¯ã€è‹±æ–‡ã§ã™ã€‚PDF(é›»å媒体)ã§ã®ç´å“ã¨ãªã‚Šã¾ã™ã€‚<br />※本レãƒãƒ¼ãƒˆã¯å–り寄ã›ã¨ãªã‚Šã¾ã™ã®ã§ã€ç”³ã—è¾¼ã¿ã‹ã‚‰ãŠå±Šã‘ã¾ã§ã€å¤šå°‘時間ãŒæŽ›ã‹ã‚‹å ´åˆãŒã”ã–ã„ã¾ã™ã€‚', 'color' => '2', 'scolor' => null, 'outline' => '<p> ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã¯2023å¹´ã‹ã‚‰2028å¹´ã«156å„„4,000万米ドルã€äºˆæ¸¬æœŸé–“ä¸ã®CAGRã¯8.4%ã§æˆé•·ã™ã‚‹ã¨äºˆæ¸¬ã•ã‚Œã¾ã™ã€‚ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã¯ã€å…¨ä½“çš„ãªåˆ†æžã€å¸‚å ´è¦æ¨¡ã¨äºˆæ¸¬ã€å‚¾å‘ã€æˆé•·ãƒ‰ãƒ©ã‚¤ãƒãƒ¼ã€èª²é¡Œã€ãŠã‚ˆã³ç´„25ã®ãƒ™ãƒ³ãƒ€ãƒ¼ã‚’ã‚«ãƒãƒ¼ã™ã‚‹ãƒ™ãƒ³ãƒ€ãƒ¼åˆ†æžã‚’æä¾›ã—ã¾ã™ã€‚ </p> <p> ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã¯ã€ç¾åœ¨ã®å¸‚å ´ã‚·ãƒŠãƒªã‚ªã€æœ€æ–°ã®å‚¾å‘ã¨æŽ¨é€²åŠ›ã€ãŠã‚ˆã³å…¨ä½“çš„ãªå¸‚å ´ç’°å¢ƒã«é–¢ã™ã‚‹æœ€æ–°ã®åˆ†æžã‚’æä¾›ã—ã¾ã™ã€‚ä¹³ãŒã‚“罹患率ã®ä¸Šæ˜‡ã€å …調ãªãƒ‘イプラインã¨æ–°è–¬æ‰¿èªã€æ‚£è€…を支æ´ã™ã‚‹å–り組ã¿ã®å¢—åŠ ãªã©ãŒå¸‚å ´ã‚’ç‰½å¼•ã—ã¦ã„ã¾ã™ã€‚ </p> <p> <span style="font-weight:bold;">調査範囲</span> </p> <ul class="rfp_mar-b1"> <li> <span style="font-weight:bold;">å¸‚å ´ã‚»ã‚°ãƒ¡ãƒ³ãƒˆ</span> <br /> <span style="font-weight:bold;">➣ 疾患タイプ別</span> <br /> 　　◇ 浸潤性乳ãŒã‚“<br /> 　　◇ éžæµ¸æ½¤æ€§ä¹³ãŒã‚“（DCIS）<br /> <span style="font-weight:bold;">➣ セラピー別</span> <br /> 　　◇ 標的療法<br /> 　　◇ ホルモン療法<br /> 　　◇ 化å¦ç™‚法<br /> <span style="font-weight:bold;">➣ 地域別</span> <br /> 　　◇ 北アメリカ<br /> 　　◇ ヨーãƒãƒƒãƒ‘<br /> 　　◇ アジア<br /> 　　◇ 世界ã®ãã®ä»–ã®åœ°åŸŸï¼ˆROW） </li> </ul> <p> 本調査ã§ã¯ã€ä»Šå¾Œæ•°å¹´é–“ã®ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®æˆé•·ã‚’牽引ã™ã‚‹ä¸»ãªè¦å› ã®1ã¤ã¨ã—ã¦ã€æ–°ãŸãªæ–°è¦æ²»ç™‚薬を挙ã’ã¦ã„ã¾ã™ã€‚ã¾ãŸã€æ”¹å–„ã•ã‚ŒãŸè¨ºæ–モダリティã®åˆ©ç”¨å¯èƒ½æ€§ã‚„戦略的ææºã®å¢—åŠ ã¯ã€å¸‚å ´ã®å¤§ããªéœ€è¦ã«ã¤ãªãŒã£ã¦ã„ã¾ã™ã€‚ </p> <p>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã«é–¢ã™ã‚‹ãƒ¬ãƒãƒ¼ãƒˆã¯ã€æ¬¡ã®åˆ†é‡Žã‚’ã‚«ãƒãƒ¼ã—ã¦ã„ã¾ã™ã€‚</p> <ul class="rfp_mar-b1"> <li>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®è¦æ¨¡</li> <li>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®äºˆæ¸¬</li> <li>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®æ¥ç•Œåˆ†æž</li> </ul> <p>å …ç‰¢ãªãƒ™ãƒ³ãƒ€ãƒ¼åˆ†æžã¯ã€ã‚¯ãƒ©ã‚¤ã‚¢ãƒ³ãƒˆãŒå¸‚å ´ã§ã®åœ°ä½ã‚’å‘上ã•ã›ã‚‹ã®ã«å½¹ç«‹ã¤ã‚ˆã†ã«è¨è¨ˆã•ã‚Œã¦ã„ã¾ã™ã€‚</p> <ul class="rfp_mar-b1"> <li> <span style="font-weight:bold;">調査ä¼æ¥</span> <br /> ➣ AbbVie Inc.<br /> ➣ Amgen Inc.<br /> ➣ AstraZeneca Plc<br /> ➣ Bristol Myers Squibb Co.<br /> ➣ Clovis Oncology Inc.<br /> ➣ 第一三共（Daiichi Sankyo Co. Ltd.）<br /> ➣ エーザイ（Eisai Co. Ltd.）<br /> ➣ Eli Lilly and Co.<br /> ➣ Exelixis Inc.<br /> ➣ F. Hoffmann La Roche Ltd.<br /> ➣ GlaxoSmithKline Plc<br /> ➣ Merck and Co. Inc.<br /> ➣ Novartis AG<br /> ➣ PerkinElmer Inc<br /> ➣ Pfizer Inc.<br /> ➣ Puma Biotechnology Inc.<br /> ➣ Sanofi SA<br /> ➣ Teva Pharmaceutical Industries Ltd.<br /> ➣ Viatris Inc. </li> </ul> <p>ã¾ãŸã€æœ¬ãƒ¬ãƒãƒ¼ãƒˆã«ã¯ã€å¸‚å ´ã®æˆé•·ã«å½±éŸ¿ã‚’与ãˆã‚‹ä»Šå¾Œã®å‚¾å‘ã¨èª²é¡Œã«é–¢ã™ã‚‹æƒ…å ±ãŒå«ã¾ã‚Œã¦ã„ã¾ã™ã€‚ã“ã‚Œã¯ã€ä¼æ¥ãŒä»Šå¾Œã®ã™ã¹ã¦ã®æˆé•·æ©Ÿä¼šã‚’戦略化ã—ã€æ´»ç”¨ã™ã‚‹ã®ã«å½¹ç«‹ã¡ã¾ã™ã€‚</p> <p> ã“ã®èª¿æŸ»ã¯ã€æ¥ç•Œã®ä¸»è¦å‚åŠ è€…ã‹ã‚‰ã®æ„見をå«ã‚€ä¸€æ¬¡æƒ…å ±ã¨äºŒæ¬¡æƒ…å ±ã‚’å®¢è¦³çš„ã«çµ„ã¿åˆã‚ã›ã¦å®Ÿæ–½ã•ã‚Œã¾ã—ãŸã€‚ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã«ã¯ã€ä¸»è¦ãƒ™ãƒ³ãƒ€ãƒ¼ã®åˆ†æžã«åŠ ãˆã¦ã€åŒ…括的ãªå¸‚å ´ã¨ãƒ™ãƒ³ãƒ€ãƒ¼ã®çŠ¶æ³ãŒå«ã¾ã‚Œã¦ã„ã¾ã™ã€‚ </p> <p> ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã¯ã€åˆ©ç›Šã€ä¾¡æ ¼è¨å®šã€ç«¶äº‰ã€ãƒ—ãƒãƒ¢ãƒ¼ã‚·ãƒ§ãƒ³ãªã©ã®ä¸»è¦ãªãƒ‘ラメーターã®åˆ†æžã«ã‚ˆã‚‹è¤‡æ•°ã®ã‚½ãƒ¼ã‚¹ã‹ã‚‰ã®ãƒ‡ãƒ¼ã‚¿ã®èª¿æŸ»ã€åˆæˆã€åˆè¨ˆã«ã‚ˆã‚Šã€å¸‚å ´ã®è©³ç´°ãªå…¨ä½“åƒã‚’æ示ã—ã¾ã™ã€‚æ¥ç•Œã®ä¸»è¦ãªå½±éŸ¿åŠ›ã‚’æŒã¤ä¼æ¥ã‚’特定ã™ã‚‹ã“ã¨ã§ã€ã•ã¾ã–ã¾ãªå¸‚å ´ã®å´é¢ã‚’示ã—ã¾ã™ã€‚æ示ã•ã‚ŒãŸãƒ‡ãƒ¼ã‚¿ã¯åŒ…括的ã§ä¿¡é ¼æ€§ãŒé«˜ãã€ä¸€æ¬¡ãŠã‚ˆã³äºŒæ¬¡ã®ä¸¡æ–¹ã«ã‚ãŸã‚‹åºƒç¯„ãªç ”究ã®çµæžœã§ã™ã€‚å¸‚å ´èª¿æŸ»ãƒ¬ãƒãƒ¼ãƒˆã¯ã€æ£ç¢ºãªå¸‚å ´ã®æˆé•·ã‚’予測ã™ã‚‹ãŸã‚ã®å®šæ€§çš„ãŠã‚ˆã³å®šé‡çš„調査を使用ã—ãŸã€å®Œå…¨ãªç«¶äº‰çŠ¶æ³ã¨è©³ç´°ãªãƒ™ãƒ³ãƒ€ãƒ¼é¸æŠžæ–¹æ³•è«–ãŠã‚ˆã³åˆ†æžã‚’æä¾›ã—ã¾ã™ã€‚ </p> ', 'memo' => '', 'catalog_copy' => '', 'pamphlet_pdf' => '0', 's_upload' => null, 'i_upload' => '1', 'update_flag' => null, 'update_date' => '2024-03-06 16:56:52', 'regist_date' => '0000-00-00 00:00:00' ) $session_carts = array() $id = null $checked_reports = array() $category_list = array( (int) 1 => array( (int) 1 => array( 'subcategory_id' => '1', 'subcategory_name' => 'デジタル放é€ãƒ»CATV', 'category_id' => '1' ), (int) 2 => array( 'subcategory_id' => '2', 'subcategory_name' => 'インターãƒãƒƒãƒˆé€šä¿¡ã‚¤ãƒ³ãƒ•ãƒ©eビジãƒã‚¹', 'category_id' => '1' ), (int) 3 => array( 'subcategory_id' => '3', 'subcategory_name' => 'æºå¸¯é›»è©±ãƒ¢ãƒã‚¤ãƒ«', 'category_id' => '1' ), (int) 4 => array( 'subcategory_id' => '4', 'subcategory_name' => 'カーエレクトãƒãƒ‹ã‚¯ã‚¹ãƒ»ITS', 'category_id' => '1' ), (int) 5 => array( 'subcategory_id' => '5', 'subcategory_name' => 'ホームãƒãƒƒãƒˆãƒ¯ãƒ¼ã‚¯æƒ…å ±å®¶é›»AV', 'category_id' => '1' ), (int) 6 => array( 'subcategory_id' => '6', 'subcategory_name' => 'DVDHDDメモリーカードデータストレージ', 'category_id' => '1' ), (int) 7 => array( 'subcategory_id' => '7', 'subcategory_name' => 'å¤§åž‹æ˜ åƒãƒ»ãƒ‡ã‚£ã‚¹ãƒ—レイ', 'category_id' => '1' ), (int) 8 => array( 'subcategory_id' => '8', 'subcategory_name' => 'デジタルコンテンツ・エンターテインメント', 'category_id' => '1' ), (int) 9 => array( 'subcategory_id' => '9', 'subcategory_name' => 'エレクトãƒãƒ‹ã‚¯ã‚¹ãƒ»IT(ãã®ä»–)', 'category_id' => '1' ) ), (int) 2 => array( (int) 1 => array( 'subcategory_id' => '1', 'subcategory_name' => '医薬å“原料・製剤', 'category_id' => '2' ), (int) 2 => array( 'subcategory_id' => '2', 'subcategory_name' => '創薬一般', 'category_id' => '2' ), (int) 3 => array( 'subcategory_id' => '3', 'subcategory_name' => 'ç–¾ç—…åˆ¥æ²»ç™‚ãƒ»é ˜åŸŸåˆ¥æ²»ç™‚', 'category_id' => '2' ), (int) 4 => array( 'subcategory_id' => '4', 'subcategory_name' => 'ãƒã‚¤ã‚ªãƒ»ã‚²ãƒŽãƒ ・å†ç”ŸåŒ»ç™‚', 'category_id' => '2' ), (int) 5 => array( 'subcategory_id' => '5', 'subcategory_name' => '診æ–・検査薬', 'category_id' => '2' ), (int) 6 => array( 'subcategory_id' => '6', 'subcategory_name' => 'アウトソーシング', 'category_id' => '2' ), (int) 7 => array( 'subcategory_id' => '7', 'subcategory_name' => 'ä¼æ¥', 'category_id' => '2' ), (int) 8 => array( 'subcategory_id' => '8', 'subcategory_name' => '医薬å“産æ¥ï¼ˆåŒ»ç™‚制度ã€åŒ»ç™‚観光ãªã©ï¼‰', 'category_id' => '2' ), (int) 9 => array( 'subcategory_id' => '9', 'subcategory_name' => '医療器具・機器', 'category_id' => '2' ), (int) 10 => array( 'subcategory_id' => '10', 'subcategory_name' => 'メディカル・ãƒã‚¤ã‚ª(ãã®ä»–)', 'category_id' => '2' ) ), (int) 3 => array( (int) 1 => array( 'subcategory_id' => '1', 'subcategory_name' => '介è·ç¦ç¥‰', 'category_id' => '3' ), (int) 2 => array( 'subcategory_id' => '2', 'subcategory_name' => 'å¥åº·ãƒ»å¥åº·é£Ÿå“・特定ä¿å¥ç”¨é£Ÿå“', 'category_id' => '3' ), (int) 3 => array( 'subcategory_id' => '3', 'subcategory_name' => 'å¥åº·é£Ÿäº‹æŒ‡å°Ž', 'category_id' => '3' ), (int) 4 => array( 'subcategory_id' => '4', 'subcategory_name' => 'å¥åº·ä¿é™º', 'category_id' => '3' ), (int) 5 => array( 'subcategory_id' => '5', 'subcategory_name' => 'メンタルヘルス', 'category_id' => '3' ), (int) 6 => array( 'subcategory_id' => '6', 'subcategory_name' => 'ウエルãƒã‚¹(ãã®ä»–)', 'category_id' => '3' ) ), (int) 4 => array( (int) 1 => array( 'subcategory_id' => '1', 'subcategory_name' => '医療ＩＴ', 'category_id' => '4' ), (int) 2 => array( 'subcategory_id' => '2', 'subcategory_name' => '医療IT(ãã®ä»–)', 'category_id' => '4' ) ), (int) 5 => array( (int) 1 => array( 'subcategory_id' => '1', 'subcategory_name' => '石ç‚・石油・天然ガス', 'category_id' => '5' ), (int) 2 => array( 'subcategory_id' => '2', 'subcategory_name' => 'ãƒã‚¤ã‚ªç‡ƒæ–™(ãƒã‚¤ã‚ªãƒ‡ã‚£ãƒ¼ã‚¼ãƒ«ãƒ»ãƒã‚¤ã‚ªã‚¨ã‚¿ãƒŽãƒ¼ãƒ«)', 'category_id' => '5' ), (int) 3 => array( 'subcategory_id' => '3', 'subcategory_name' => 'スマートグリッド・スマートシティ', 'category_id' => '5' ), (int) 4 => array( 'subcategory_id' => '4', 'subcategory_name' => '太陽光', 'category_id' => '5' ), (int) 5 => array( 'subcategory_id' => '5', 'subcategory_name' => 'é›»æ± ãƒ»EV', 'category_id' => '5' ), (int) 6 => array( 'subcategory_id' => '6', 'subcategory_name' => '環境', 'category_id' => '5' ), (int) 7 => array( 'subcategory_id' => '7', 'subcategory_name' => 'エãƒãƒ«ã‚®ãƒ¼ãƒ»ç’°å¢ƒ(ãã®ä»–)', 'category_id' => '5' ) ), (int) 6 => array( (int) 1 => array( 'subcategory_id' => '1', 'subcategory_name' => 'å€‹äººæƒ…å ±ä¿è·', 'category_id' => '6' ), (int) 2 => array( 'subcategory_id' => '2', 'subcategory_name' => '知的財産', 'category_id' => '6' ), (int) 3 => array( 'subcategory_id' => '3', 'subcategory_name' => '経営マãƒã‚¸ãƒ¡ãƒ³ãƒˆ', 'category_id' => '6' ), (int) 4 => array( 'subcategory_id' => '4', 'subcategory_name' => 'ãã®ä»–', 'category_id' => '6' ) ) ) $category_sub_list = array( (int) 0 => array( 'CategoryMain' => array( 'category_id' => '1', 'category_name' => 'エレクトãƒãƒ‹ã‚¯ã‚¹ãƒ»IT' ), 'CategorySub' => array( (int) 0 => array( [maximum depth reached] ), (int) 1 => array( [maximum depth reached] ), (int) 2 => array( [maximum depth reached] ), (int) 3 => array( [maximum depth reached] ), (int) 4 => array( [maximum depth reached] ), (int) 5 => array( [maximum depth reached] ), (int) 6 => array( [maximum depth reached] ), (int) 7 => array( [maximum depth reached] ), (int) 8 => array( [maximum depth reached] ) ) ), (int) 1 => array( 'CategoryMain' => array( 'category_id' => '2', 'category_name' => 'メディカル・ãƒã‚¤ã‚ª' ), 'CategorySub' => array( (int) 0 => array( [maximum depth reached] ), (int) 1 => array( [maximum depth reached] ), (int) 2 => array( [maximum depth reached] ), (int) 3 => array( [maximum depth reached] ), (int) 4 => array( [maximum depth reached] ), (int) 5 => array( [maximum depth reached] ), (int) 6 => array( [maximum depth reached] ), (int) 7 => array( [maximum depth reached] ), (int) 8 => array( [maximum depth reached] ), (int) 9 => array( [maximum depth reached] ) ) ), (int) 2 => array( 'CategoryMain' => array( 'category_id' => '3', 'category_name' => 'ウエルãƒã‚¹' ), 'CategorySub' => array( (int) 0 => array( [maximum depth reached] ), (int) 1 => array( [maximum depth reached] ), (int) 2 => array( [maximum depth reached] ), (int) 3 => array( [maximum depth reached] ), (int) 4 => array( [maximum depth reached] ), (int) 5 => array( [maximum depth reached] ) ) ), (int) 3 => array( 'CategoryMain' => array( 'category_id' => '4', 'category_name' => '医療IT' ), 'CategorySub' => array( (int) 0 => array( [maximum depth reached] ), (int) 1 => array( [maximum depth reached] ) ) ), (int) 4 => array( 'CategoryMain' => array( 'category_id' => '5', 'category_name' => 'エãƒãƒ«ã‚®ãƒ¼ãƒ»ç’°å¢ƒ' ), 'CategorySub' => array( (int) 0 => array( [maximum depth reached] ), (int) 1 => array( [maximum depth reached] ), (int) 2 => array( [maximum depth reached] ), (int) 3 => array( [maximum depth reached] ), (int) 4 => array( [maximum depth reached] ), (int) 5 => array( [maximum depth reached] ), (int) 6 => array( [maximum depth reached] ) ) ), (int) 5 => array( 'CategoryMain' => array( 'category_id' => '6', 'category_name' => 'ビジãƒã‚¹ä¸€èˆ¬ãƒ»ãã®ä»–' ), 'CategorySub' => array( (int) 0 => array( [maximum depth reached] ), (int) 1 => array( [maximum depth reached] ), (int) 2 => array( [maximum depth reached] ), (int) 3 => array( [maximum depth reached] ) ) ) ) $category_main_list = array( (int) 1 => 'エレクトãƒãƒ‹ã‚¯ã‚¹ãƒ»IT', (int) 2 => 'メディカル・ãƒã‚¤ã‚ª', (int) 3 => 'ウエルãƒã‚¹', (int) 4 => '医療IT', (int) 5 => 'エãƒãƒ«ã‚®ãƒ¼ãƒ»ç’°å¢ƒ', (int) 6 => 'ビジãƒã‚¹ä¸€èˆ¬ãƒ»ãã®ä»–' ) $tax = '0.1' $content_for_layout = ' <style type="text/css"> @media screen and (min-width: 980px) { .report_patarn_license{ display:flex; } } .report_discription p { margin-bottom:10px; } .report_discription .details { margin-bottom:20px; } .report_discription .details h4 { padding:10px 0px; font-size:18px; border-top:1px solid #666; border-bottom:1px solid #666; margin:0px 0px 10px 0px; } .report_discription .details table { border-collapse:collapse; border-spacing:0px; width:100%; } .report_discription .details table th { background-color: #006dc3; background-color:lightblue; } .report_discription .details table th, .report_discription .details table td { /*border:1px solid #999; padding:5px;*/ /*border:none;*/ } /* table th,table td{ border:1px solid #999; padding:5px; } */ .report_discription .details .mu_table th, .report_discription .details .mu_table td { /*border:1px solid #999; padding:5px;*/ border:none; } .tooltip_favorite { position:absolute; left :800px; margin : 5px; display: inline-block; text-align: center; min-width: 120px; max-width: 100%; color: #006dc3; font-size: 16px; background: #fff; border : solid 1px; border-color : #005bb8; border-radius: 30px; } .sample_report{ border: none; background-color: transparent; font-size: 15px; color:#299cbd; cursor:pointer } .license_table{ empty-cells: show; border-right:1px solid #ccc; font-size:16px; margin:5px 5px; } .license_td{ text-align:center; vertical-align: middle; color:#fff; border-bottom:1px solid #ccc; background-color:#006dc3; border-bottom:1px solid #ccc; border-left:1px solid #ccc; border:1; height:50px; width:200px; font-size:15px; } .price_td{ text-align:center; vertical-align: middle; background-color:#fff; border-bottom:1px solid #ccc; border-right:1px solid #ccc; border:1; height:50px; width:200px; font-size:17px; } .format_td{ text-align:center; vertical-align: middle; background-color:#006dc3; border-bottom:1px solid #ccc; border-right:1px solid #ccc; border:1; height:50px; width:200px; font-size:17px; color:white; } .btn_cart_div{ display:flex; text-align:center; -webkit-justify-content: center; margin:20px 0px; padding:0px 50px; } </style> <div class="breadcrumb clearfix"> <ul> <li class="home"><a href="/">ホーム</a></li> <li><a href="/categories/index/?m_id=2">メディカル・ãƒã‚¤ã‚ª</a></li> <li>ä¹³ãŒã‚“治療薬ã®ä¸–ç•Œå¸‚å ´ï¼ˆ2024-2028）</li> </ul> </div><!--/breadcrumb--> <div class="detail_main"> <form action="/categories/detail/37546?url=categories%2Fdetail%2F37546" id="detailForm" method="post" accept-charset="utf-8"><div style="display:none;"><input type="hidden" name="_method" value="POST"/></div> <div class="detail_mainIn"> <div class="detail_main_box"> <p class="report_number">レãƒãƒ¼ãƒˆãƒŠãƒ³ãƒãƒ¼ã€€0000037546</p> <div class="category"><a href="/categories/index/?m_id=2&s_id=1">医薬å“原料・製剤</a></div> <div class="category"><a href="/categories/index/?m_id=2&s_id=2">創薬一般</a></div> <div class="category"><a href="/categories/index/?m_id=2&s_id=3">ç–¾ç—…åˆ¥æ²»ç™‚ãƒ»é ˜åŸŸåˆ¥æ²»ç™‚</a></div> <h3>ä¹³ãŒã‚“治療薬ã®ä¸–ç•Œå¸‚å ´ï¼ˆ2024-2028）</h3> <p class="company">TechNavio</p> <p class="subTitle"></p> <p class="subTitle"></p> <p class="subTitle">Global Breast Cancer Therapeutics Market 2024-2028</p> <div class="data"> <p><span>発刊日</span> 2024/01/18</p> <p><span>言語</span>英語</p> <p><span>体è£</span>PDF/168ページ</p> </div> </div><!--/detail_main_box--> <div class="detail_cart_area"> <div class="report_patarn clearfix"> <p class="report_patarnIn">ライセンス/ä¾¡æ ¼<span>168ページ</span></p> <p class="report_sub_number"> 0000037546 </p> </div> <div class="report_patarn_license clearfix"> <!--<p class="license_text"> ä¹³ãŒã‚“治療薬ã®ä¸–ç•Œå¸‚å ´ï¼ˆ2024-2028）<br> Global Breast Cancer Therapeutics Market 2024-2028 </p>--> <div class= "cart_div"> <table border=1 class="license_table"><!--<p class="license_price">--> <tbody> <!--<tr> <td class="license_td"> Single </td> <td class="license_td"> Enterprise </td> </tr>--> <tr> <th class="license_td"> Single </th> <td class="price_td"> <input type="radio" name="data[ReportBase][license]" class="license_radio" id="license" value="1" checked/> <label for="license">2,500USD</label><br> </td> </tr> <tr> <th class="license_td"> Enterprise </th> <td class="price_td"> <input type="radio" name="data[ReportBase][license]" class="license_radio" id="license2" value="2" /> <label for="license2">4,000USD</label><br> </td> </tr> </tr> </tr> </tr> </tr> </tr> </tr> </tbody> </table><!--</p>--> </div> <div class="btn_cart_div"> <div class="btn_cart"> <input type="hidden" name="data[carts]" value="37546" id="carts"/> <button name="carts_add" id="carts_add">カートã¸</button> </div><!--/btn_cart--> <div class="btn_cart"> <input type="hidden" name="data[carts]" value="37546" id="carts"/> <button name="carts_now" id="carts_now">今ã™ã購入</button> </div><!--/btn_cart--> </div><!--/cart_div--> </div> </div><!--/detail_cart_area--> <p>※ã”請求ã¯ã€ãŠç”³è¾¼æ—¥ã®TTSレートã§å††æ›ç®—ã—ã€æ¶ˆè²»ç¨Žã‚’åŠ ãˆãŸé‡‘é¡ã«ãªã‚Šã¾ã™ã€‚<br />※本レãƒãƒ¼ãƒˆã¯ã€è‹±æ–‡ã§ã™ã€‚PDF(é›»å媒体)ã§ã®ç´å“ã¨ãªã‚Šã¾ã™ã€‚<br />※本レãƒãƒ¼ãƒˆã¯å–り寄ã›ã¨ãªã‚Šã¾ã™ã®ã§ã€ç”³ã—è¾¼ã¿ã‹ã‚‰ãŠå±Šã‘ã¾ã§ã€å¤šå°‘時間ãŒæŽ›ã‹ã‚‹å ´åˆãŒã”ã–ã„ã¾ã™ã€‚</p> <div class="btn_report_set"> <div class="btn01" style="margin:0px auto;"> <!--<button type="submit" class="contact" value="product_id">商å“ã‚’å•ã„åˆã‚ã›ã‚‹</button>--> <a href="https://www.spi-information.com/contacts/report_contact?report=37546&sample=0">ãŠå•ã„åˆã‚ã›</a> </div> <div class="btn01" style="margin:0px auto;"><a href="https://www.spi-information.com/contacts/report_contact?report=37546&sample=1">サンプルä¾é ¼</a></div> <button class="btn-form-cart" name="estimate" value="1">見ç©æ›¸ä½œæˆ</button> </div><!--/btn_report_set--> <div class="sample_box"> <p>無料サンプル</p> <ul> <li>サンプルã¯ãŠå•ã„åˆã‚ã›ãã ã•ã„。</li> </ul> </div><!--/sample_box--> <div class="report_discription"> <h3>レãƒãƒ¼ãƒˆæ¦‚è¦</h3> <p> ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã¯2023å¹´ã‹ã‚‰2028å¹´ã«156å„„4,000万米ドルã€äºˆæ¸¬æœŸé–“ä¸ã®CAGRã¯8.4%ã§æˆé•·ã™ã‚‹ã¨äºˆæ¸¬ã•ã‚Œã¾ã™ã€‚ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã¯ã€å…¨ä½“çš„ãªåˆ†æžã€å¸‚å ´è¦æ¨¡ã¨äºˆæ¸¬ã€å‚¾å‘ã€æˆé•·ãƒ‰ãƒ©ã‚¤ãƒãƒ¼ã€èª²é¡Œã€ãŠã‚ˆã³ç´„25ã®ãƒ™ãƒ³ãƒ€ãƒ¼ã‚’ã‚«ãƒãƒ¼ã™ã‚‹ãƒ™ãƒ³ãƒ€ãƒ¼åˆ†æžã‚’æä¾›ã—ã¾ã™ã€‚ </p> <p> ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã¯ã€ç¾åœ¨ã®å¸‚å ´ã‚·ãƒŠãƒªã‚ªã€æœ€æ–°ã®å‚¾å‘ã¨æŽ¨é€²åŠ›ã€ãŠã‚ˆã³å…¨ä½“çš„ãªå¸‚å ´ç’°å¢ƒã«é–¢ã™ã‚‹æœ€æ–°ã®åˆ†æžã‚’æä¾›ã—ã¾ã™ã€‚ä¹³ãŒã‚“罹患率ã®ä¸Šæ˜‡ã€å …調ãªãƒ‘イプラインã¨æ–°è–¬æ‰¿èªã€æ‚£è€…を支æ´ã™ã‚‹å–り組ã¿ã®å¢—åŠ ãªã©ãŒå¸‚å ´ã‚’ç‰½å¼•ã—ã¦ã„ã¾ã™ã€‚ </p> <p> <span style="font-weight:bold;">調査範囲</span> </p> <ul class="rfp_mar-b1"> <li> <span style="font-weight:bold;">å¸‚å ´ã‚»ã‚°ãƒ¡ãƒ³ãƒˆ</span> <br /> <span style="font-weight:bold;">➣ 疾患タイプ別</span> <br /> 　　◇ 浸潤性乳ãŒã‚“<br /> 　　◇ éžæµ¸æ½¤æ€§ä¹³ãŒã‚“（DCIS）<br /> <span style="font-weight:bold;">➣ セラピー別</span> <br /> 　　◇ 標的療法<br /> 　　◇ ホルモン療法<br /> 　　◇ 化å¦ç™‚法<br /> <span style="font-weight:bold;">➣ 地域別</span> <br /> 　　◇ 北アメリカ<br /> 　　◇ ヨーãƒãƒƒãƒ‘<br /> 　　◇ アジア<br /> 　　◇ 世界ã®ãã®ä»–ã®åœ°åŸŸï¼ˆROW） </li> </ul> <p> 本調査ã§ã¯ã€ä»Šå¾Œæ•°å¹´é–“ã®ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®æˆé•·ã‚’牽引ã™ã‚‹ä¸»ãªè¦å› ã®1ã¤ã¨ã—ã¦ã€æ–°ãŸãªæ–°è¦æ²»ç™‚薬を挙ã’ã¦ã„ã¾ã™ã€‚ã¾ãŸã€æ”¹å–„ã•ã‚ŒãŸè¨ºæ–モダリティã®åˆ©ç”¨å¯èƒ½æ€§ã‚„戦略的ææºã®å¢—åŠ ã¯ã€å¸‚å ´ã®å¤§ããªéœ€è¦ã«ã¤ãªãŒã£ã¦ã„ã¾ã™ã€‚ </p> <p>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã«é–¢ã™ã‚‹ãƒ¬ãƒãƒ¼ãƒˆã¯ã€æ¬¡ã®åˆ†é‡Žã‚’ã‚«ãƒãƒ¼ã—ã¦ã„ã¾ã™ã€‚</p> <ul class="rfp_mar-b1"> <li>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®è¦æ¨¡</li> <li>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®äºˆæ¸¬</li> <li>ä¹³ãŒã‚“æ²»ç™‚è–¬å¸‚å ´ã®æ¥ç•Œåˆ†æž</li> </ul> <p>å …ç‰¢ãªãƒ™ãƒ³ãƒ€ãƒ¼åˆ†æžã¯ã€ã‚¯ãƒ©ã‚¤ã‚¢ãƒ³ãƒˆãŒå¸‚å ´ã§ã®åœ°ä½ã‚’å‘上ã•ã›ã‚‹ã®ã«å½¹ç«‹ã¤ã‚ˆã†ã«è¨è¨ˆã•ã‚Œã¦ã„ã¾ã™ã€‚</p> <ul class="rfp_mar-b1"> <li> <span style="font-weight:bold;">調査ä¼æ¥</span> <br /> ➣ AbbVie Inc.<br /> ➣ Amgen Inc.<br /> ➣ AstraZeneca Plc<br /> ➣ Bristol Myers Squibb Co.<br /> ➣ Clovis Oncology Inc.<br /> ➣ 第一三共（Daiichi Sankyo Co. Ltd.）<br /> ➣ エーザイ（Eisai Co. Ltd.）<br /> ➣ Eli Lilly and Co.<br /> ➣ Exelixis Inc.<br /> ➣ F. Hoffmann La Roche Ltd.<br /> ➣ GlaxoSmithKline Plc<br /> ➣ Merck and Co. Inc.<br /> ➣ Novartis AG<br /> ➣ PerkinElmer Inc<br /> ➣ Pfizer Inc.<br /> ➣ Puma Biotechnology Inc.<br /> ➣ Sanofi SA<br /> ➣ Teva Pharmaceutical Industries Ltd.<br /> ➣ Viatris Inc. </li> </ul> <p>ã¾ãŸã€æœ¬ãƒ¬ãƒãƒ¼ãƒˆã«ã¯ã€å¸‚å ´ã®æˆé•·ã«å½±éŸ¿ã‚’与ãˆã‚‹ä»Šå¾Œã®å‚¾å‘ã¨èª²é¡Œã«é–¢ã™ã‚‹æƒ…å ±ãŒå«ã¾ã‚Œã¦ã„ã¾ã™ã€‚ã“ã‚Œã¯ã€ä¼æ¥ãŒä»Šå¾Œã®ã™ã¹ã¦ã®æˆé•·æ©Ÿä¼šã‚’戦略化ã—ã€æ´»ç”¨ã™ã‚‹ã®ã«å½¹ç«‹ã¡ã¾ã™ã€‚</p> <p> ã“ã®èª¿æŸ»ã¯ã€æ¥ç•Œã®ä¸»è¦å‚åŠ è€…ã‹ã‚‰ã®æ„見をå«ã‚€ä¸€æ¬¡æƒ…å ±ã¨äºŒæ¬¡æƒ…å ±ã‚’å®¢è¦³çš„ã«çµ„ã¿åˆã‚ã›ã¦å®Ÿæ–½ã•ã‚Œã¾ã—ãŸã€‚ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã«ã¯ã€ä¸»è¦ãƒ™ãƒ³ãƒ€ãƒ¼ã®åˆ†æžã«åŠ ãˆã¦ã€åŒ…括的ãªå¸‚å ´ã¨ãƒ™ãƒ³ãƒ€ãƒ¼ã®çŠ¶æ³ãŒå«ã¾ã‚Œã¦ã„ã¾ã™ã€‚ </p> <p> ã“ã®ãƒ¬ãƒãƒ¼ãƒˆã¯ã€åˆ©ç›Šã€ä¾¡æ ¼è¨å®šã€ç«¶äº‰ã€ãƒ—ãƒãƒ¢ãƒ¼ã‚·ãƒ§ãƒ³ãªã©ã®ä¸»è¦ãªãƒ‘ラメーターã®åˆ†æžã«ã‚ˆã‚‹è¤‡æ•°ã®ã‚½ãƒ¼ã‚¹ã‹ã‚‰ã®ãƒ‡ãƒ¼ã‚¿ã®èª¿æŸ»ã€åˆæˆã€åˆè¨ˆã«ã‚ˆã‚Šã€å¸‚å ´ã®è©³ç´°ãªå…¨ä½“åƒã‚’æ示ã—ã¾ã™ã€‚æ¥ç•Œã®ä¸»è¦ãªå½±éŸ¿åŠ›ã‚’æŒã¤ä¼æ¥ã‚’特定ã™ã‚‹ã“ã¨ã§ã€ã•ã¾ã–ã¾ãªå¸‚å ´ã®å´é¢ã‚’示ã—ã¾ã™ã€‚æ示ã•ã‚ŒãŸãƒ‡ãƒ¼ã‚¿ã¯åŒ…括的ã§ä¿¡é ¼æ€§ãŒé«˜ãã€ä¸€æ¬¡ãŠã‚ˆã³äºŒæ¬¡ã®ä¸¡æ–¹ã«ã‚ãŸã‚‹åºƒç¯„ãªç ”究ã®çµæžœã§ã™ã€‚å¸‚å ´èª¿æŸ»ãƒ¬ãƒãƒ¼ãƒˆã¯ã€æ£ç¢ºãªå¸‚å ´ã®æˆé•·ã‚’予測ã™ã‚‹ãŸã‚ã®å®šæ€§çš„ãŠã‚ˆã³å®šé‡çš„調査を使用ã—ãŸã€å®Œå…¨ãªç«¶äº‰çŠ¶æ³ã¨è©³ç´°ãªãƒ™ãƒ³ãƒ€ãƒ¼é¸æŠžæ–¹æ³•è«–ãŠã‚ˆã³åˆ†æžã‚’æä¾›ã—ã¾ã™ã€‚ </p> <h3>レãƒãƒ¼ãƒˆè©³ç´°</h3> <div class="details"> <h4>目次</h4> <p> <span style="font-weight:bold;">Table of Contents</span> </p> <p> <span style="font-weight:bold;">1 Executive Summary</span> <br /> 1.1 Market overview<br /> Exhibit 01: Executive Summary - Chart on Market Overview<br /> Exhibit 02: Executive Summary - Data Table on Market Overview<br /> Exhibit 03: Executive Summary - Chart on Global Market Characteristics<br /> Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape<br /> Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type<br /> Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapy<br /> Exhibit 07: Executive Summary - Chart on Incremental Growth<br /> Exhibit 08: Executive Summary - Data Table on Incremental Growth<br /> Exhibit 09: Executive Summary - Chart on Vendor Market Positioning </p> <p> <span style="font-weight:bold;">2 Market Landscape</span> <br /> 2.1 Market ecosystem<br /> Exhibit 10: Parent market<br /> Exhibit 11: Market Characteristics </p> <p> <span style="font-weight:bold;">3 Market Sizing</span> <br /> 3.1 Market definition<br /> Exhibit 12: Offerings of vendors included in the market definition<br /> 3.2 Market segment analysis<br /> Exhibit 13: Market segments<br /> 3.3 Market size 2023<br /> 3.4 Market outlook: Forecast for 2023-2028<br /> Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)<br /> Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%) </p> <p> <span style="font-weight:bold;">4 Historic Market Size</span> <br /> 4.1 Global breast cancer therapeutics market 2018 - 2022<br /> Exhibit 18: Historic Market Size - Data Table on global breast cancer therapeutics market 2018 - 2022 ($ billion)<br /> 4.2 Disease Type Segment Analysis 2018 - 2022<br /> Exhibit 19: Historic Market Size - Disease Type Segment 2018 - 2022 ($ billion)<br /> 4.3 Therapy Segment Analysis 2018 - 2022<br /> Exhibit 20: Historic Market Size - Therapy Segment 2018 - 2022 ($ billion)<br /> 4.4 Geography Segment Analysis 2018 - 2022<br /> Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)<br /> 4.5 Country Segment Analysis 2018 - 2022<br /> Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion) </p> <p> <span style="font-weight:bold;">5 Five Forces Analysis</span> <br /> 5.1 Five forces summary<br /> Exhibit 23: Five forces analysis - Comparison between 2023 and 2028<br /> 5.2 Bargaining power of buyers<br /> Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028<br /> 5.3 Bargaining power of suppliers<br /> Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028<br /> 5.4 Threat of new entrants<br /> Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028<br /> 5.5 Threat of substitutes<br /> Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028<br /> 5.6 Threat of rivalry<br /> Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028<br /> 5.7 Market condition<br /> Exhibit 29: Chart on Market condition - Five forces 2023 and 2028 </p> <p> <span style="font-weight:bold;">6 Market Segmentation by Disease Type</span> <br /> 6.1 Market segments<br /> Exhibit 30: Chart on Disease Type - Market share 2023-2028 (%)<br /> Exhibit 31: Data Table on Disease Type - Market share 2023-2028 (%)<br /> 6.2 Comparison by Disease Type<br /> Exhibit 32: Chart on Comparison by Disease Type<br /> Exhibit 33: Data Table on Comparison by Disease Type<br /> 6.3 Invasive breast cancers - Market size and forecast 2023-2028<br /> Exhibit 34: Chart on Invasive breast cancers - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 35: Data Table on Invasive breast cancers - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 36: Chart on Invasive breast cancers - Year-over-year growth 2023-2028 (%)<br /> Exhibit 37: Data Table on Invasive breast cancers - Year-over-year growth 2023-2028 (%)<br /> 6.4 Ductal carcinoma in situ - Market size and forecast 2023-2028<br /> Exhibit 38: Chart on Ductal carcinoma in situ - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 39: Data Table on Ductal carcinoma in situ - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 40: Chart on Ductal carcinoma in situ - Year-over-year growth 2023-2028 (%)<br /> Exhibit 41: Data Table on Ductal carcinoma in situ - Year-over-year growth 2023-2028 (%)<br /> 6.5 Market opportunity by Disease Type<br /> Exhibit 42: Market opportunity by Disease Type ($ billion)<br /> Exhibit 43: Data Table on Market opportunity by Disease Type ($ billion) </p> <p> <span style="font-weight:bold;">7 Market Segmentation by Therapy</span> <br /> 7.1 Market segments<br /> Exhibit 44: Chart on Therapy - Market share 2023-2028 (%)<br /> Exhibit 45: Data Table on Therapy - Market share 2023-2028 (%)<br /> 7.2 Comparison by Therapy<br /> Exhibit 46: Chart on Comparison by Therapy<br /> Exhibit 47: Data Table on Comparison by Therapy<br /> 7.3 Targeted therapy - Market size and forecast 2023-2028<br /> Exhibit 48: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 49: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 50: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)<br /> Exhibit 51: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)<br /> 7.4 Hormonal therapy - Market size and forecast 2023-2028<br /> Exhibit 52: Chart on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 53: Data Table on Hormonal therapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 54: Chart on Hormonal therapy - Year-over-year growth 2023-2028 (%)<br /> Exhibit 55: Data Table on Hormonal therapy - Year-over-year growth 2023-2028 (%)<br /> 7.5 Chemotherapy - Market size and forecast 2023-2028<br /> Exhibit 56: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 57: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 58: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)<br /> Exhibit 59: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)<br /> 7.6 Market opportunity by Therapy<br /> Exhibit 60: Market opportunity by Therapy ($ billion)<br /> Exhibit 61: Data Table on Market opportunity by Therapy ($ billion) </p> <p> <span style="font-weight:bold;">8 Customer Landscape</span> <br /> 8.1 Customer landscape overview<br /> Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria </p> <p> <span style="font-weight:bold;">9 Geographic Landscape</span> <br /> 9.1 Geographic segmentation<br /> Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)<br /> Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)<br /> 9.2 Geographic comparison<br /> Exhibit 65: Chart on Geographic comparison<br /> Exhibit 66: Data Table on Geographic comparison<br /> 9.3 North America - Market size and forecast 2023-2028<br /> Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)<br /> Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)<br /> 9.4 Europe - Market size and forecast 2023-2028<br /> Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)<br /> Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)<br /> 9.5 Asia - Market size and forecast 2023-2028<br /> Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)<br /> Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)<br /> 9.6 Rest of World (ROW) - Market size and forecast 2023-2028<br /> Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)<br /> Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)<br /> 9.7 US - Market size and forecast 2023-2028<br /> Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)<br /> Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)<br /> 9.8 Germany - Market size and forecast 2023-2028<br /> Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)<br /> Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)<br /> 9.9 Canada - Market size and forecast 2023-2028<br /> Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)<br /> Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)<br /> 9.10 UK - Market size and forecast 2023-2028<br /> Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)<br /> Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)<br /> 9.11 China - Market size and forecast 2023-2028<br /> Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)<br /> Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)<br /> Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)<br /> 9.12 Market opportunity By Geographical Landscape<br /> Exhibit 103: Market opportunity By Geographical Landscape ($ billion)<br /> Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion) </p> <p> <span style="font-weight:bold;">10 Drivers, Challenges, and Trends</span> <br /> 10.1 Market drivers<br /> 10.2 Market challenges<br /> 10.3 Impact of drivers and challenges<br /> Exhibit 105: Impact of drivers and challenges in 2023 and 2028<br /> 10.4 Market trends </p> <p> <span style="font-weight:bold;">11 Vendor Landscape</span> <br /> 11.1 Overview<br /> 11.2 Vendor landscape<br /> Exhibit 106: Overview on Criticality of inputs and Factors of differentiation<br /> 11.3 Landscape disruption<br /> Exhibit 107: Overview on factors of disruption<br /> 11.4 Industry risks<br /> Exhibit 108: Impact of key risks on business </p> <p> <span style="font-weight:bold;">12 Vendor Analysis</span> <br /> 12.1 Vendors covered<br /> Exhibit 109: Vendors covered<br /> 12.2 Market positioning of vendors<br /> Exhibit 110: Matrix on vendor position and classification<br /> 12.3 AbbVie Inc.<br /> Exhibit 111: AbbVie Inc. - Overview<br /> Exhibit 112: AbbVie Inc. - Product / Service<br /> Exhibit 113: AbbVie Inc. - Key news<br /> Exhibit 114: AbbVie Inc. - Key offerings<br /> 12.4 Amgen Inc.<br /> Exhibit 115: Amgen Inc. - Overview<br /> Exhibit 116: Amgen Inc. - Product / Service<br /> Exhibit 117: Amgen Inc. - Key offerings<br /> 12.5 AstraZeneca Plc<br /> Exhibit 118: AstraZeneca Plc - Overview<br /> Exhibit 119: AstraZeneca Plc - Product / Service<br /> Exhibit 120: AstraZeneca Plc - Key news<br /> Exhibit 121: AstraZeneca Plc - Key offerings<br /> 12.6 Bristol Myers Squibb Co.<br /> Exhibit 122: Bristol Myers Squibb Co. - Overview<br /> Exhibit 123: Bristol Myers Squibb Co. - Product / Service<br /> Exhibit 124: Bristol Myers Squibb Co. - Key news<br /> Exhibit 125: Bristol Myers Squibb Co. - Key offerings<br /> 12.7 Clovis Oncology Inc.<br /> Exhibit 126: Clovis Oncology Inc. - Overview<br /> Exhibit 127: Clovis Oncology Inc. - Product / Service<br /> Exhibit 128: Clovis Oncology Inc. - Key offerings<br /> 12.8 Daiichi Sankyo Co. Ltd.<br /> Exhibit 129: Daiichi Sankyo Co. Ltd. - Overview<br /> Exhibit 130: Daiichi Sankyo Co. Ltd. - Product / Service<br /> Exhibit 131: Daiichi Sankyo Co. Ltd. - Key news<br /> Exhibit 132: Daiichi Sankyo Co. Ltd. - Key offerings<br /> 12.9 Eisai Co. Ltd.<br /> Exhibit 133: Eisai Co. Ltd. - Overview<br /> Exhibit 134: Eisai Co. Ltd. - Business segments<br /> Exhibit 135: Eisai Co. Ltd. - Key offerings<br /> Exhibit 136: Eisai Co. Ltd. - Segment focus<br /> 12.10 Eli Lilly and Co.<br /> Exhibit 137: Eli Lilly and Co. - Overview<br /> Exhibit 138: Eli Lilly and Co. - Product / Service<br /> Exhibit 139: Eli Lilly and Co. - Key news<br /> Exhibit 140: Eli Lilly and Co. - Key offerings<br /> 12.11 Exelixis Inc.<br /> Exhibit 141: Exelixis Inc. - Overview<br /> Exhibit 142: Exelixis Inc. - Product / Service<br /> Exhibit 143: Exelixis Inc. - Key offerings<br /> 12.12 F. Hoffmann La Roche Ltd.<br /> Exhibit 144: F. Hoffmann La Roche Ltd. - Overview<br /> Exhibit 145: F. Hoffmann La Roche Ltd. - Business segments<br /> Exhibit 146: F. Hoffmann La Roche Ltd. - Key news<br /> Exhibit 147: F. Hoffmann La Roche Ltd. - Key offerings<br /> Exhibit 148: F. Hoffmann La Roche Ltd. - Segment focus<br /> 12.13 GlaxoSmithKline Plc<br /> Exhibit 149: GlaxoSmithKline Plc - Overview<br /> Exhibit 150: GlaxoSmithKline Plc - Business segments<br /> Exhibit 151: GlaxoSmithKline Plc - Key news<br /> Exhibit 152: GlaxoSmithKline Plc - Key offerings<br /> Exhibit 153: GlaxoSmithKline Plc - Segment focus<br /> 12.14 Merck and Co. Inc.<br /> Exhibit 154: Merck and Co. Inc. - Overview<br /> Exhibit 155: Merck and Co. Inc. - Business segments<br /> Exhibit 156: Merck and Co. Inc. - Key news<br /> Exhibit 157: Merck and Co. Inc. - Key offerings<br /> Exhibit 158: Merck and Co. Inc. - Segment focus<br /> 12.15 Novartis AG<br /> Exhibit 159: Novartis AG - Overview<br /> Exhibit 160: Novartis AG - Business segments<br /> Exhibit 161: Novartis AG - Key offerings<br /> Exhibit 162: Novartis AG - Segment focus<br /> 12.16 Pfizer Inc.<br /> Exhibit 163: Pfizer Inc. - Overview<br /> Exhibit 164: Pfizer Inc. - Product / Service<br /> Exhibit 165: Pfizer Inc. - Key news<br /> Exhibit 166: Pfizer Inc. - Key offerings<br /> 12.17 Viatris Inc.<br /> Exhibit 167: Viatris Inc. - Overview<br /> Exhibit 168: Viatris Inc. - Business segments<br /> Exhibit 169: Viatris Inc. - Key news<br /> Exhibit 170: Viatris Inc. - Key offerings<br /> Exhibit 171: Viatris Inc. - Segment focus </p> <p> <span style="font-weight:bold;">13 Appendix</span> <br /> 13.1 Scope of the report<br /> 13.2 Inclusions and exclusions checklist<br /> Exhibit 172: Inclusions checklist<br /> Exhibit 173: Exclusions checklist<br /> 13.3 Currency conversion rates for US$<br /> Exhibit 174: Currency conversion rates for US$<br /> 13.4 Research methodology<br /> Exhibit 175: Research methodology<br /> Exhibit 176: Validation techniques employed for market sizing<br /> Exhibit 177: Information sources<br /> 13.5 List of abbreviations<br /> Exhibit 178: List of abbreviations </p> </div> </div><!--/report_discription--> <div class="btn_report_set"> <div class="btn01"> <a href="/guides">ãŠè²·ã„物ガイド</a> </div><!--/btn01--> <div class="btn01"> <a href="/questions">よãã‚る質å•</a> </div><!--/btn01--> </div><!--/btn_report_set--> <div class="tel_guide clearfix"> <a href="tel:0358125270"><img src="/img/./category/suport_tel_03.jpg" alt=""/></a> <div class="report_no"> <p>ã“ã®å•†å“ã®ãƒ¬ãƒãƒ¼ãƒˆãƒŠãƒ³ãƒãƒ¼</p> <p class="report_no_box">0000037546</p> </div> </div><!--/tel_guide--> </div> </form> </div> <script type="text/javascript"> $('#carts_add').css("cursor","pointer"); $('#carts_now').css("cursor","pointer"); $('#heart_off').css("cursor","pointer"); $('.heart_off').css("cursor","pointer"); $(function(){ if($('#stlist').length){ $('.btn_cart').fadeOut(); } }); $(function () { $('.tooltip_favorite').hide(); $('div').hover( function () { $(this).children('.tooltip_favorite').fadeIn('fast'); }, function () { $(this).children('.tooltip_favorite').fadeOut('fast'); }); }); </script> ' $scripts_for_layout = '' $title_for_layout = 'Categories'header - [internal], line ?? include - APP/View/Layouts/spi-information.ctp, line 2 View::_evaluate() - CORE/Cake/View/View.php, line 971 View::_render() - CORE/Cake/View/View.php, line 933 View::renderLayout() - CORE/Cake/View/View.php, line 546 View::render() - CORE/Cake/View/View.php, line 481 Controller::render() - CORE/Cake/Controller/Controller.php, line 968 Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200 Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167 [main] - APP/webroot/index.php, line 118
Copyright c SPI Information,Inc. 2019 All rights reserved.
Warning (2): Unknown: open(/tmp//sess_884771a7daf0ada2f5743239aa1b8227, O_RDWR) failed: Disc quota exceeded (69) [Unknown, line 0]Code Context$GLOBALS = array( 'GLOBALS' => [recursion], '_ENV' => array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php' ), 'HTTP_ENV_VARS' => array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php' ), '_POST' => array(), 'HTTP_POST_VARS' => array(), '_GET' => array( 'url' => 'categories/detail/37546' ), 'HTTP_GET_VARS' => array( 'url' => 'categories/detail/37546' ), '_COOKIE' => array(), 'HTTP_COOKIE_VARS' => array(), '_SERVER' => array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php', 'PHP_SELF' => '/app/webroot/index.php', 'REQUEST_TIME' => (int) 1748712594, 'argv' => array( (int) 0 => 'url=categories/detail/37546' ), 'argc' => (int) 1 ), 'HTTP_SERVER_VARS' => array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php', 'PHP_SELF' => '/app/webroot/index.php', 'REQUEST_TIME' => (int) 1748712594, 'argv' => array( (int) 0 => 'url=categories/detail/37546' ), 'argc' => (int) 1 ), '_FILES' => array(), 'HTTP_POST_FILES' => array(), '_REQUEST' => array( 'url' => 'categories/detail/37546' ), 'vendorPath' => '/home/spi-information/www/app/Vendor/cakephp/cakephp/lib', 'dispatcher' => 'Cake/Console/ShellDispatcher.php', 'encoding' => 'UTF-8', 'Dispatcher' => object(Dispatcher) { [protected] _eventManager => object(CakeEventManager) {} }, 'HTTP_SESSION_VARS' => array( 'Config' => array( 'userAgent' => 'dc9e586010a78aa48b50058743b65b01', 'time' => (int) 1904232594, 'countdown' => (int) 10 ), 'CheckedReports' => array( (int) 0 => '37546' ) ), '_SESSION' => array( 'Config' => array( 'userAgent' => 'dc9e586010a78aa48b50058743b65b01', 'time' => (int) 1904232594, 'countdown' => (int) 10 ), 'CheckedReports' => array( (int) 0 => '37546' ) ) ) $_ENV = array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php' ) $HTTP_ENV_VARS = array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php' ) $_POST = array() $HTTP_POST_VARS = array() $_GET = array( 'url' => 'categories/detail/37546' ) $HTTP_GET_VARS = array( 'url' => 'categories/detail/37546' ) $_COOKIE = array() $HTTP_COOKIE_VARS = array() $_SERVER = array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php', 'PHP_SELF' => '/app/webroot/index.php', 'REQUEST_TIME' => (int) 1748712594, 'argv' => array( (int) 0 => 'url=categories/detail/37546' ), 'argc' => (int) 1 ) $HTTP_SERVER_VARS = array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php', 'PHP_SELF' => '/app/webroot/index.php', 'REQUEST_TIME' => (int) 1748712594, 'argv' => array( (int) 0 => 'url=categories/detail/37546' ), 'argc' => (int) 1 ) $_FILES = array() $HTTP_POST_FILES = array() $_REQUEST = array( 'url' => 'categories/detail/37546' ) $vendorPath = '/home/spi-information/www/app/Vendor/cakephp/cakephp/lib' $dispatcher = 'Cake/Console/ShellDispatcher.php' $encoding = 'UTF-8' $Dispatcher = object(Dispatcher) { [protected] _eventManager => object(CakeEventManager) {} } $HTTP_SESSION_VARS = array( 'Config' => array( 'userAgent' => 'dc9e586010a78aa48b50058743b65b01', 'time' => (int) 1904232594, 'countdown' => (int) 10 ), 'CheckedReports' => array( (int) 0 => '37546' ) ) $_SESSION = array( 'Config' => array( 'userAgent' => 'dc9e586010a78aa48b50058743b65b01', 'time' => (int) 1904232594, 'countdown' => (int) 10 ), 'CheckedReports' => array( (int) 0 => '37546' ) )session_write_close - [internal], line ?? [main] - [internal], line ??
Warning (2): Unknown: Failed to write session data (files). Please verify that the current setting of session.save_path is correct () [Unknown, line 0]Code Context$GLOBALS = array( 'GLOBALS' => [recursion], '_ENV' => array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php' ), 'HTTP_ENV_VARS' => array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php' ), '_POST' => array(), 'HTTP_POST_VARS' => array(), '_GET' => array( 'url' => 'categories/detail/37546' ), 'HTTP_GET_VARS' => array( 'url' => 'categories/detail/37546' ), '_COOKIE' => array(), 'HTTP_COOKIE_VARS' => array(), '_SERVER' => array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php', 'PHP_SELF' => '/app/webroot/index.php', 'REQUEST_TIME' => (int) 1748712594, 'argv' => array( (int) 0 => 'url=categories/detail/37546' ), 'argc' => (int) 1 ), 'HTTP_SERVER_VARS' => array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php', 'PHP_SELF' => '/app/webroot/index.php', 'REQUEST_TIME' => (int) 1748712594, 'argv' => array( (int) 0 => 'url=categories/detail/37546' ), 'argc' => (int) 1 ), '_FILES' => array(), 'HTTP_POST_FILES' => array(), '_REQUEST' => array( 'url' => 'categories/detail/37546' ), 'vendorPath' => '/home/spi-information/www/app/Vendor/cakephp/cakephp/lib', 'dispatcher' => 'Cake/Console/ShellDispatcher.php', 'encoding' => 'UTF-8', 'Dispatcher' => object(Dispatcher) { [protected] _eventManager => object(CakeEventManager) {} }, 'HTTP_SESSION_VARS' => array( 'Config' => array( 'userAgent' => 'dc9e586010a78aa48b50058743b65b01', 'time' => (int) 1904232594, 'countdown' => (int) 10 ), 'CheckedReports' => array( (int) 0 => '37546' ) ), '_SESSION' => array( 'Config' => array( 'userAgent' => 'dc9e586010a78aa48b50058743b65b01', 'time' => (int) 1904232594, 'countdown' => (int) 10 ), 'CheckedReports' => array( (int) 0 => '37546' ) ) ) $_ENV = array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php' ) $HTTP_ENV_VARS = array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php' ) $_POST = array() $HTTP_POST_VARS = array() $_GET = array( 'url' => 'categories/detail/37546' ) $HTTP_GET_VARS = array( 'url' => 'categories/detail/37546' ) $_COOKIE = array() $HTTP_COOKIE_VARS = array() $_SERVER = array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php', 'PHP_SELF' => '/app/webroot/index.php', 'REQUEST_TIME' => (int) 1748712594, 'argv' => array( (int) 0 => 'url=categories/detail/37546' ), 'argc' => (int) 1 ) $HTTP_SERVER_VARS = array( 'PHPRC' => '/home/spi-information/www', 'PATH' => '/usr/local/bin:/usr/bin:/bin', 'REDIRECT_STATUS' => '200', 'HTTPS' => 'on', 'HTTP_AUTHORIZATION' => '', 'HTTP_HOST' => 'www.spi-information.com', 'HTTP_X_REAL_IP' => '18.216.186.122', 'HTTP_LISTEN_IPADDR' => '133.167.8.188', 'HTTP_PRAGMA' => 'no-cache', 'HTTP_CACHE_CONTROL' => 'no-cache', 'HTTP_SEC_CH_UA' => '"Chromium";v="130", "HeadlessChrome";v="130", "Not?A_Brand";v="99"', 'HTTP_SEC_CH_UA_MOBILE' => '?0', 'HTTP_SEC_CH_UA_PLATFORM' => '"Windows"', 'HTTP_UPGRADE_INSECURE_REQUESTS' => '1', 'HTTP_USER_AGENT' => 'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)', 'HTTP_ACCEPT' => 'text/html,application/xhtml+xml,application/xml;q=0.9,image/avif,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.7', 'HTTP_SEC_FETCH_SITE' => 'none', 'HTTP_SEC_FETCH_MODE' => 'navigate', 'HTTP_SEC_FETCH_USER' => '?1', 'HTTP_SEC_FETCH_DEST' => 'document', 'HTTP_ACCEPT_ENCODING' => 'gzip, deflate, br, zstd', 'HTTP_PRIORITY' => 'u=0, i', 'SERVER_SIGNATURE' => '', 'SERVER_SOFTWARE' => 'Apache', 'SERVER_NAME' => 'www.spi-information.com', 'SERVER_ADDR' => '100.64.0.57', 'SERVER_PORT' => '443', 'REMOTE_HOST' => 'ec2-18-216-186-122.us-east-2.compute.amazonaws.com', 'REMOTE_ADDR' => '18.216.186.122', 'DOCUMENT_ROOT' => '/home/spi-information/www/', 'REQUEST_SCHEME' => 'https', 'CONTEXT_PREFIX' => '', 'CONTEXT_DOCUMENT_ROOT' => '/home/spi-information/www/', 'SERVER_ADMIN' => '[no address given]', 'SCRIPT_FILENAME' => '/home/spi-information/www/app/webroot/index.php', 'REMOTE_PORT' => '0', 'REDIRECT_URL' => '/app/webroot/categories/detail/37546', 'REDIRECT_QUERY_STRING' => 'url=categories/detail/37546', 'GATEWAY_INTERFACE' => 'CGI/1.1', 'SERVER_PROTOCOL' => 'HTTP/1.1', 'REQUEST_METHOD' => 'GET', 'QUERY_STRING' => 'url=categories/detail/37546', 'REQUEST_URI' => '/categories/detail/37546', 'SCRIPT_NAME' => '/app/webroot/index.php', 'PHP_SELF' => '/app/webroot/index.php', 'REQUEST_TIME' => (int) 1748712594, 'argv' => array( (int) 0 => 'url=categories/detail/37546' ), 'argc' => (int) 1 ) $_FILES = array() $HTTP_POST_FILES = array() $_REQUEST = array( 'url' => 'categories/detail/37546' ) $vendorPath = '/home/spi-information/www/app/Vendor/cakephp/cakephp/lib' $dispatcher = 'Cake/Console/ShellDispatcher.php' $encoding = 'UTF-8' $Dispatcher = object(Dispatcher) { [protected] _eventManager => object(CakeEventManager) {} } $HTTP_SESSION_VARS = array( 'Config' => array( 'userAgent' => 'dc9e586010a78aa48b50058743b65b01', 'time' => (int) 1904232594, 'countdown' => (int) 10 ), 'CheckedReports' => array( (int) 0 => '37546' ) ) $_SESSION = array( 'Config' => array( 'userAgent' => 'dc9e586010a78aa48b50058743b65b01', 'time' => (int) 1904232594, 'countdown' => (int) 10 ), 'CheckedReports' => array( (int) 0 => '37546' ) )session_write_close - [internal], line ?? [main] - [internal], line ??
